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Abstract
Qualitative and quantitative analysis through digital imaging has significant
potential in several scientific applications including bioanalytical applications. In
this document, the implication of digital imaging to validate and characterize a
novel microfluidic organ-on-chip device and establish a point-of-care method to
estimate epinephrine concentrations in expired and degraded autoinjectors have
been described in chapter 2 and 3 respectively. Chapter 4 includes description of
the principle and methodology of strong cation exchange-based immunoassay for
oxytocin and β-endorphin.
In chapter 2, fabrication of a novel microfluidic organ-on-chip device capable of
culturing rodent SCN slices has been discussed. Characterization of the aCSF
media droplets and carbogen gas bubbles have also been discussed. Viability of
the cultured rodent brain slices using digital imagery through fluorescence calcium
imaging and PI/DAPI staining have been reported. In chapter 3, utilization of
quantitative smartphone imaging to estimate the concentration of epinephrine in
expired and degraded autoinjectors have been described. Actual concentrations
of the samples have been established by UHPLC technique. The estimated
concentrations of the samples via quantitative smartphone imaging have been
reported to possess a strong correlation (r > 0.7) with the actual concentration.
Different lighting conditions, distance and angle of camera variations have been
explored in chapter 3.
Direct immunoassay of relatively small neurotransmitters (~1-5 KDa) through
capillary electrophoresis is prone to poor resolution challenge. The principle of
using strong cation exchange-based chromatography to carry out such
immunoassays have been described in chapter 4. The possible use of crosslinking
agents such as sulfo-GMBS and sulfo-SMPB to improve antigen-antibody binding
has also been discussed in this chapter. Chapter 5 explores the future directions
of improving the rodent slice culture device to accommodate various size and
shape of brain slices by chamber geometry and surface energy optimization.
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Chapter 1
1. Introduction
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1.1 Background concepts on microfluidic
approaches to brain slice culture
1.1.1 Objective
The tissue-on-a-chip approach for rodent brain culture is an emerging field of
research in ex vivo modeling of neurobiology. Tissue-on-a-chip can offer online
measurements of tissue secretions and integration to sophisticated analytical tools
for selective and sensitive measurement. This approach also minimizes bio-waste
and limit reagent usage promoting greener techniques. The project described in
chapter 2 aims to achieve a microfluidic slice culture device which can complete
the following goals: 1. Mimicking roller tube slice culture method in microfluidic
platforms, 2. Maintaining slice viability for short to long term experiments, and 3.
Establishing a platform to be integrable to analytical instruments for selective and
sensitive measurements of tissue secretions.
Completing these goals will result in exploiting the benefits of the roller tube
slice culture method in addition to the benefits of the microfluidic platform. The
roller tube method, described below, is known for better oxygenation of the slice
resulting in prolonged slice viability. A slice viable for days to weeks can be ideal
candidates for studying the secretion profiles to investigate the tissue’s circadian
characteristics or response to external stimuli. Integration of analytical instruments
will enable studying upregulations or downregulations of cellular secretions due to
external or internal stimuli in real time with high spatial and temporal resolution. To
be able to complete these goals, a microfluidic flow device needs to be developed
with precise control over the fluid flow and oxygen delivery. Proper housing of the
slice with sufficient tissue adhesion is essential to withstand the stress from the
fluid flow. The viability of the cultured tissue slice needs to be confirmed via
techniques such as calcium imaging and PI/DAPI staining of the cell nucleus.
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1.1.2 Roller tube method for rodent brain slice culture
Culture experiments of brain slices are a common practice in neurophysiology
to study basic mechanisms of the brain [1-3]. A slice of the area of interest of an
animal brain isolated for experiments require constant nutrients and oxygen supply
due to the absence of the normal supply. Neuronal cells have an above average
oxygen demand to thrive [4] and hence require continuous oxygen supply. There
are numerous approaches for tissue perfusion described in the literature and they
can be broadly classified to two categories [5]. In the first category, brain slices are
submerged in oxygen rich artificial cerebrospinal fluid (aCSF). In the second
category, brain slices are placed on an interface above aCSF with oxygen rich
surroundings. In both categories, nutrients and oxygen penetrate the slice by
diffusion, starting from the outer cells to the inner cells.

Figure 1: Roller tube for brain slice culture
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A roller tube approach can be labeled as a combination of these two categories
where the slice is adhered to a substrate placed inside a tube partially filled with
aCSF and oxygen rich air [6]. The tube rotates along with the substrate and as a
result, the slice is alternatively submerged into the aCSF and exposed to the
oxygen (Figure 1) This approach allows maximum surface area of the slice to come
into contact to both aCSF and oxygen in contrast to the other approaches. All these
approaches are often used in experiments involving the measurements of the cell
potentials related to neurophysiological activities [7]. The aCSF collects molecules
secreted from the brain slice when in contact. Periodically analyzing the aCSF can
potentially be important in studies of the secreted molecules and their response to
outside stimuli. However, the concentration of the molecules of interest would be
diluted to multiple orders of magnitude compared to in vivo concentrations due to
the very low amounts of such secreted analytes [8] and the use of comparatively
large volumes (mL) of the aCSF. The detection limits and the sensitivities of many
common analysis techniques may not be suitable for such analyses. The
measurements of analytes in the aCSF will not provide highly resolved temporal
information since the media solution cannot be replaced in very short time
intervals. To overcome these challenges, a microfluidic mimic of the roller tube
approach is developed in chapter 2 of this dissertation. Although secretion
measurements have not yet been demonstrated in this system, it is designed to
limit the dilution of secreted analytes and offer secretion measurements highly
resolved in the time domain.
The roller tube method has extensive applications reported in the literature
where rodent brain slices had been viable for a few day days to a few months.
Ostergaard and co-workers have applied the roller tube slice culture method to
investigate tyrosine hydroxylase which is a biomarker of dopaminergic neuron and
fibers. The method was successful in culturing the slices for up to 60 days which
demonstrates the effective nutrient and oxygen delivery approach [9]. Roller tube
method has also been reported to successfully culture sagittal cross-section of
whole rodent brain slices to investigate cholinergic and dopaminergic neurons,
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effect of pathological triggers such as hydrogen peroxide on the dye stained nuclei,
and factors contributing to Alzheimer’s and Parkinson’s disease [10]. Rodent brain
tissue slices containing suprachiasmatic nuclei (SCN) have been studied in
cultures modeled in roller tubes multiples times by several groups [11-14]. The
circadian rhythm of rodent SCN is well-established and current topic of research
by many scientists [15-17]. Studying rodent brain slices containing SCN by novel
approaches will allow comparative studies and enable validation. Calcium
response in SCN slices can be impacted by implementing receptor associated
proteins (RAP). RAP acts as LDL inhibitors [18] which in result is hypothesized to
suppress calcium responses in SCN slices stimulated by high concentration of
potassium solution. SCN slices can be incubated with RAP to assess the
suppression/recovery of the calcium responses due to LDL inhibition. The
perfusate in the form of droplets will be collected to study the SCN secretion profile
such as vasopressin and vasoactive intestinal peptide through mass-spectrometry.
The perfusate droplets can also be investigated for ATP molecules through
chemiluminescence. Mimicking of the roller tube method with microfluidic
approach may bring new possibilities for microscopy and analysis of secreted
molecules. This innovation has potential to address several analytical challenges
of investigating regulation of hormones by improving measurement sensitivity and
temporal resolution.

1.1.3 Microfluidic brain slice culture
Microfluidic devices for brain tissue culture is a significant improvement from
conventional interface and submerged techniques. Microfluidic approaches for
tissue culture can improve the penetration of oxygen and nutrients to the slice,
enhance spatial and temporal resolution of measured responses by providing
better controllability over the fluid flow, and widen the horizon of tissue experiments
by opening up the opportunities of integration of modern microscopic and
electrophysiological methods for improved experiments [19]. In vitro experiments
on cultured brain cells offer a lot of opportunities to study cellular mechanisms of

5

neurobiology, but such approaches typically fail to provide accurate models of
specific brain regions, processes, and neural connections. A brain slice harvested
from an animal immediately after decapitating it can be preserved by providing
necessary nutrients and oxygen [20], and preserves cytoarchitecture, neural
connections, and other important features not found in cell culture models.
Microfluidic approaches to brain slice culture can improve the oxygen and
nutrient penetration by introducing interstitial flow. Interstitial flow of fluids through
the slice can enable culturing thicker slices which can offer better preservation of
the cytoarchitecture. Brain slices can be fixated inside microfluidic devices by
anchor posts creating interstitial pathways. Laminar flow of nutrients can be guided
through these pathways for better penetration of the nutrients [21, 22]. Another
approach for introducing the interstitial flow is to utilize the Bernoulli effect. The
slice will be place inside a microfluidic device in between an upper and a lower
channel. The flowrate of the nutrient fluid will be faster in the lower channel and
slower in the upper channel. There will be a pressure gradient between the
channels which will make the fluid flow through the interstitial space of the slice
from the slower fluid flow channel to the faster fluid flow channel [23]. Figure 2
illustrates an example of a microfluidic device for brain slice culture involving
interstitial fluid flow. By carefully designing the shape and size of microfluidic
channels, fluid flow manipulation can be implemented to treat different regions of
the slice according to the necessity of the experiments. The spatial resolution of
the tissue responses can be significantly improved in the microfluidic approach [24,
25]. Contrarily, in the conventional techniques the spatial resolution of the tissue
responses is limited by the size of the entire tissue. Similarly, the temporal
resolution of the tissue responses in the microfluidic approach can be improved
since it inherently involves low fluid volumes [19]. Small volumes of fluid can entrap
cellular secretions without any significant dilution effect which can improve any
measurement sensitivity afterwards. Frequent exposers of small droplets to the
slice can notably improve the temporal resolution of subsequent measurements,
as Kennedy and coworkers have demonstrated with pancreatic tissue [26].
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Figure 2: Schematic of a microfluidic slice culture device involving
interstitial flow

Microfluidic slice culture devices enable integration of techniques like
microscopy and electrophysiology. Neuroscientists are interested in all regions of
the brain, and although stereotaxis allows electrical and fluidic probe insertion to
deep brain regions, in vivo experiments do not allow easy microscopic
observations to the internal regions. Contrarily, brain slices cultured in microfluidic
devices expose the internal regions including neural connections on the surface to
be easily observed. Additionally, microfluidic devices are often prepared with
optically transparent materials which enables integration of microscopy technique
with proper magnification. The integration of electrophysiological methods to the
microfluidic slice culture devices are reported to be more challenging, but several
research groups have addressed the issue. Open access microfluidic devices have
been developed to allow probes to access the slice through removable parts of the
device [27]. Other microfluidic approaches include microelectrode arrays
embedded within the device for recording electrophysiological responses with
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spatial resolution [28, 29]. Such approaches have been used for reestablishing
neural connections between two physically isolated brain slices [30] and
recuperating medullary slices which can be used to initiate breathing activity if
connected to a functionable lung [31, 32].
Numerous novel directions and improvements of conventional slice culture
techniques provided by the microfluidic approach can also present some
limitations. Fluid flow inside microfluidic channels may introduce shear stress to
the slice resulting in displacement and damage [33]. Such experiments require
careful consideration in regulating the fluid flow rate to avoid fatal shear stress.
Microfluidic channels are known to hold on to small gas bubbles at the corners and
channel walls where salt residue from earlier experiments may remain. Thorough
cleaning in between experiments are essential to avoid the gas bubble issue [34].
Another limitation of the microfluidic slice culture devices can be the use of PDMS
as a fabrication material. PDMS is known to absorb small hydrophobic molecules
which may interact with subsequent experiments [34]. Disposable PDMS devices
can be a possible solution for this issue since replication of PDMS microfluidic
devices is generally not complex and inexpensive.

1.1.4 Monodispersed bubble and droplet generation
Monodispersed refers to having uniform sizes. Working with monodispersed
bubbles and droplets in microfluidics enable uniform volume characteristics in
applications such as material synthesis [35-37], chemical synthesis [38], drug
formulation [39], and fluid dynamics [40, 41]. Generating monodispersed bubble
and droplets for microfluidic brain slice culture can greatly improve the analysis of
the secreted molecules. To be able to accurately measure the contents of droplets
which have interacted with the brain slice, control over the dimensions of the
bubbles and the droplets is essential. Since the channels of typical microfluidic
device have uniform width and depth, the volume of the droplets and bubbles will
be dependent on the length which will result in controlling several
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Figure 3: Monodispersed carbogen bubble and aCSF droplet
generation at a microfluidic T-junction

other factors such as mixing time, dispersion time, and sample volume [42]. The
length of the bubbles or droplets can be described according to equation 1 [43].
𝐿
𝑄𝑑𝑖𝑠𝑝
= 𝛼+ 𝛽
𝑤
𝑄𝑐𝑜𝑛𝑡

1

Here, L is the length of the bubble or droplet, w is the width of the microfluidic
channel, Qdisp and Qcont are the flowrates of the dispersed and continuous phase
respectively, and α and β are channel geometry dependent constants. The values
of these constants are in the order of 1. Gas phase fluids can be dispersed to a
continuous flow of liquid resulting in alternative gas bubbles and media droplets a
microfluidic device [44]. The flow of both the phases come into contact of each
other in a T-junction and the continuous phase would squeeze the disperse phase
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leading to the bubble generation. The alternate gas bubbles and liquid droplets
can be composed of carbogen (95% O2 and 5% CO2) gas and aCSF media
respectively and would be passed over an SCN slice placed in a chamber
downstream of the T-junction.(Figure 3) The aCSF droplets on the other side of
the chamber would possibly contain secreted molecules from the SCN slice and
can be analyzed for further investigations. The concentration of the analyte of
interests would be minimally diluted since a single droplet volume would be in the
low µL regime and would not come into contact of other droplets due to the
segmentation by gas bubbles. The measurements will have temporal resolution
dependent on the frequency of droplets coming into contact of the SCN slice.

1.1.5 Tissue adhesion
Tissue adhesion is a critical barrier to perform slice culture using the roller tube
method. Without adequate tissue adhesion, brain slices in the culture container or
device can be displaced by container movement or fluid flow in the microfluidic
channels. Tissue adhesion approaches retain the slices in the desired positions
for proper nutrient delivery and observing tissue responses due to experimental
stimulations. There are several approaches for adhering brain slices during culture
in either conventional or microfluidic methods. In this dissertation, two different
approaches will be discussed which are namely, physical, and chemical
approaches.
Physical approaches of tissue adhesion involve including physical anchors in
the culture container or device. In microfluidic slice culture devices, such anchors
can easily be fashioned and attached. In some cases, the anchors can be
fabricated as components of the microfluidic device. The physical approach can
be very effective in holding on to the slice and usually tolerant to significant amount
of shear stress without displacement. But physical approaches have limitations
which may not be ideal for specific experiments. Introducing an extra component
inside the microfluidic device increases spots for air bubbles to hold on to. The
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Figure 4: An example of the physical approach of tissue adhesion

surface energy inside the microfluidic device may alter due to added anchors which
may disrupt the fluid flow. Moreover, the anchor itself may put stress on the slice
resulting in damage and disrupt the experiment. In Figure 4, an example of the
physical approach of tissue adhesion is demonstrated. The fashioned hook is seen
to cause entrapment of an air bubble interrupting usual fluid flow. Several other
similar examples are shown in appendix A (Figure 31).
Using plasma clot as an adhesive material is well studied and widely reported
in the literature as a chemical approach for tissue adhesion [21, 45-47]. Blood
plasma contains fibrinogen which acts as a blood coagulating agent in vertebrates
[48]. Fibrinogen is produced in the liver and gets circulated to the entire body
through blood circulatory system. In the presence of thrombin enzyme, water
soluble fibrinogen converts to water insoluble fibrin [49]. The conversion process
is rapid, as a result precise transfer protocol needs to be maintained to attach the
slice on to a freshly applied plasma-thrombin mixture on a surface. The conversion
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Figure 5: Incapability of plasma clot as an adhesion approach for
the microfluidic bubble perfusion device

process adheres the slice to the surface and disallows displacement during
container movement or fluid flow in the microfluidic channels. While plasma clot
approach has been proved to be successful in numerous brain slice culture studies
for tissue adhesion, the retaining capability was unable to withstand the shear
stress (Figure 5) in the microfluidic experiments described in chapter 2. For the
purpose ensuring adequate tissue adhesion for the project described in chapter 2,
a stronger adhesive compound was required.
Nontoxic and bio-degradable adhesive material is also a matter of interest to
medical surgeon’s which can be used as an alternative approach to sutures. A
significant body of research exists to develop and implement such adhesive
materials in the surgery process [50-55]. Balakrishnan and co-workers have
developed a hydrogel based adhesive which provides rapid gelation and proved
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Figure 6: Reaction schematic of the hydrogel based
tissue adhesive material [56]

to be non-toxic and bio-degradable [56]. Chitosan treated with HCl was combined
with dextran dialdehyde to form the hydrogel based adhesive material (reaction
scheme in Figure 6). The novel adhesive material was extensively studied to
observe the non-toxicity, biocompatibility, and biodegradability. In addition to
perform all the said functions, the novel adhesive material also has hemostatic and
drug carrier capabilities which can be very useful in surgery applications. The
material also remains simple and inexpensive to synthesize. This novel adhesive
material was used as a tissue adhesive in all the perfusion experiments described
in chapter 2. The SOP of synthesizing the adhesive is in APPENDIX B.

1.1.6 Brain slice viability in the perfusion experiments
A fluorescent calcium imaging technique was utilized to confirm slice viability
in the experiments described in chapter 2. Intracellular [Ca 2+] is correlated to
physiological and pathological activity of neurons [57]. Ca2+ acts as a messenger
in the cellular level triggering physiological activities such as proliferation,
migration, survival, and apoptosis [58-60]. Typical intracellular [Ca2+] falls in the
range of 50-100 nM [61]. α1 subunits of the voltage-gated calcium channels
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Figure 7: Principle of calcium imaging
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(VGCC) in neuron cells are Ca2+ permeable [62]. Generally, cells in higher
organisms possess a internal net negative charge in reference to the outside
environment. Depolarization is a process when the net internal charge transforms
to a temporary positive phase. The VGCCs open for Ca2+ during depolarization of
the cell membranes. Influx of positive charges like K + can depolarize the cell
membrane initiating the opening of the VGCCs. As a result, the intracellular [Ca 2+]
increases. Subsequent repolarization of the cell membrane reestablishes the
resting period of the cells. Fluo-4 AM is a cell membrane permeable dye. The
acetoxy methyl ester groups present in the dye molecule mask the charged nature
to make it membrane permeable [63]. An SCN slice can be loaded with the dye
before placing in the microfluidic perfusion device. The loading process needs to
occur for a minimum 1 hour for rodent brain slices while maintain the proper
nutrient and oxygen supply. The masking groups in the Fluo-4 AM dye gets
hydrolyzed inside the cells in the presence of esterase enzyme and Fluo-4 AM
converts to a cell impermeable Fluo-4 dye. Figure 7 shows the principle of calcium
imaging.
Periodical stimuli of K+ to the SCN slices will depolarize the cell membranes
resulting to increase intracellular [Ca2+]. Ca2+ binds to Fluo-4 forming a fluorescent
complex (λex 488 nm and λem 515 nm) [64]. Measuring the fluorescence following
a K+ stimulus can confirm intracellular Ca2+ activity and hence confirm the viability
of the SCN slice in the microfluidic perfusion device. To measure the fluorescence
of the Ca2+ and Fluo-4 complex, the dye loaded brain slice needs to be irradiated
with a light source. The incident light should be passed through a bandpass filter
allowing 488 nm wavelength to pass. The fluorescence light should be passed
through a bandpass filter allowing the 515 nm wavelength to pass and be recorded.
Depolarization of cell membranes can increase [Ca2+] 10x which enables
significance change in the fluorescence activity [61].
Propidium iodide (PI)/Diaminophenylindol (DAPI) (structures in Figure 8)
staining was carried out as an additional technique to confirm the viability of the

15

Figure 8: Molecular structure of a. propidium iodide,
b. paraformaldehyde, and c. diaminophenylindol

slices used in the experiments described in chapter 2. PI and DAPI are commonly
used dyes for nucleus staining. Both PI and DAPI dye is permeable to dead cells
due to damaged cell membrane. PI molecules interact inside the double helix DNA
of nucleus and DAPI is known to bind itself to the minor groove of the double helix
DNA. Both the molecules fluoresce after interacting with the cell nucleus
components. These dyes can be used to determine the viability of a rodent brain
slice by utilizing the fixation method. Fixation of cells implies preservation of biotissues because of degradation due to internal enzymes or external factors.
Paraformaldehyde (PFA) is a widely used cell fixation agent. The rodent brain
slice can be treated with PI prefixation to stain the dead cells at a given time point.
Post treatment with PI dye, the slice can be treated with PFA for fixation to take
place. During fixation, PFA modifies the amino acids and peptide bonds by adding
sidechains which results to protein stabilization and the morphology of the slice is
preserved. The DAPI staining of the nucleus of the cells must follow the fixation
process [65]. The cells inside a fixed tissue slice are not viable, so DAPI can
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penetrate them through the damaged cell membrane. The PI stained cells before
fixation will appear magenta and all the DAPI stained cells which were not stained
by PI dye will appear blue. The ration of these colored cells can be used to
determine the viability of the tissue slice before fixation.

1.1.7 Summary
Background concepts pertaining to our microfluidic approach for mimicking
roller tube tissue culture method are described. The mechanism of monodispersed
bubble generation in a microfluidic T-junction is discussed. Proper tissue adhesion
protocol and appropriate slice viability confirming experiments are also outlined in
this section.

1.2 Background concepts on quantitative
smartphone imaging for epinephrine dose
estimation
1.2.1 Objective
The price of commercial epinephrine drugs has increased 10-fold since 2009
[66, 67]. This increase in price has encouraged the tendency of not replacing
expired epinephrine among patients [68, 69]. In addition to that, lack of proper
storage degrades and discolors the epinephrine. Doctors and manufacturers
discourage using expired and degraded epinephrine. In the practice of austere
medicine or wilderness medicine, fresh supply of epinephrine is scarce and the
unpredictable weather in the remote places may not offer proper storage for the
medicine. In such circumstances, the only possible way to treat an anaphylactic
patient with an expired and/or degraded epinephrine auto-injector.
Presence of epinephrine in expired autoinjectors is established in the literature
[70]. But study with degraded autoinjectors is absent, and a point-of-care
estimation method is not established. In this project, we aim to study primarily
expired autoinjectors. We also aim to establish a quantitative smartphone imaging-
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based point-of-care epinephrine concentration estimation method for degraded
autoinjectors. The project takes several possible imaging conditions into account
before establishing the quantitative method. We also focus on achieving a narrow
confidence interval band for the concentration estimation near the standard
epinephrine dosage. The success of the project can be helpful for medical
professionals in their decision-making process of using an expired and degraded
epinephrine autoinjector during an emergency when no other viable alternative is
not available. We do not advocate using expired autoinjectors in this project. The
wider medical community is more knowledgeable and better equipped to make that
decision. This project only intends to offer an estimation tool for emergency
circumstances.

1.2.2 Anaphylaxis
Anaphylaxis is a medical condition which exerts hyperallergic reactions in the
patient affecting multiple parts of the organ system. The condition may be triggered
by external stimuli such as food, medicine, and envenomation. The most common
symptoms of anaphylaxis include itchy rash, swelling of throat area, difficulty in
breathing, vomiting, weakness, and abnormal blood pressure.
The mechanism of anaphylactic shock in the human body is initiated by abrupt
secretion of mast cells and basophil-derived mediators into the blood circulatory
system [71]. The mechanism is classified into two categories, namely Immunologic
or non-immunologic. The immunologic mechanism can either be IgE-dependent or
IgG-dependent [72]. The mechanism pair is widely studied on rodent systems and
is speculated to be applicable to human systems in a similar manner [73]. In the
IgE-dependent mechanism, allergen induced cross-linking of high-affinity
receptors from mast cells and basophils cause the release of inflammatory
mediators and cytokinesis. This event leads to increased vascular permeability and
smooth muscle contraction [74, 75]. The stated conditions are strongly associated
with anaphylaxis. The IgG dependent mechanism involve macrophage and require
a larger amount of antibody-antigen activity [75-78]. Platelet activating factor which
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is responsible for initiating blood clot is released in both the mechanisms resulting
in increasing risk for the patient. The non-immunologic mechanism is triggered by
external factors such as extreme temperatures, substance use, and use of certain
anti-biotics which may dysregulate the mast cells and the basophils leading to
anaphylaxis. This mechanism does not involve any immunological molecule [75,
78].
The trigger factors of anaphylaxis can be identified in many sources. Some
common food sources responsible for anaphylaxis are nuts, gluten, shellfish, dairy,
and beans. Penicillin, aspirin, vancomycin, morphine, selected cancer drugs, and
vaccines are some of the common medication sources responsible for
anaphylaxis. Stings from ants, bees, wasps, and kissing bugs are known
envenomation sources responsible for anaphylaxis. Atopic disease patients such
as patients suffering from asthma, eczema, and allergic rhinitis bear a higher threat
of an anaphylactic attack due to exposure of any of the triggers.
The diagnosis of anaphylaxis is primarily dependent on the symptoms of the
patient. The exposure to an allergen leading to two or more symptoms of
anaphylaxis may be an initial indicator. Presence of histamine in blood may confirm
anaphylaxis if triggered by medicine or envenomation but remains inconclusive if
triggered by food [73]. Other medical conditions such as asthma, syncope or panic
attacks may have overlapping symptoms but can be segregated by the presence
of itching and gastrointestinal symptoms in case of anaphylaxis.
Approximately 2-5% of the population get anaphylactic attack in the USA each
year and approximately 1000 people die as a result [79]. Anaphylaxis can be
prevented by avoiding exposure to known allergens. An anaphylactic episode
should be addressed by an anti-allergen drug at the earliest to mitigate
complications and avoid fatality. Delay in treatment may lead to hospitalization and
further complications.
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1.2.3 Epinephrine
Epinephrine or Adrenaline (Figure 9) is a hormone produced in the adrenal
glands and medulla oblongata. It is widely used as a treatment for anaphylaxis.
The pharmacology of epinephrine allows it to alleviate the severe effects of
anaphylaxis. Epinephrine binds to at least two receptors, termed alpha, and beta.
The binding of epinephrine with alpha receptors decreases peripheral vasodilation
which helps reduce elevated blood pressure, erythema, urticaria, and angioedema
[80]. The binding of epinephrine with beta receptors causes bronchodilation to help
breathing problems and suppress mast cells and basophils release [80]. As a
result, epinephrine can treat abnormal blood pressure by enhancing blood flow,
difficulty in breathing by loosening muscles in the lungs system, and blocking
allergic reaction initiating cells. Therefore, epinephrine is considered the most
preferable drug to treat anaphylaxis.

Figure 9: Molecular structure of epinephrine
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Delay in administering epinephrine is correlated with poor performance of the
drug by achieving delayed plasma peak concentration [81, 82]. Other reasons for
poor performance of the drug include underlying diseases of the patient, lack of
sufficient available dose of epinephrine in the drug, and presence of systematic
disorders in the patient. Epinephrine is reported to have a very narrow therapeutic
window [80]. Administering lower amount of epinephrine to the patient will have no
significant benefit, and on the other hand overdose of epinephrine have
occasionally led to myocardial infraction or ischemia, pulmonary edema,
accelerated hypertension, and intracranial hemorrhage. Common side effects of
epinephrine include palpitations, headache, anxiety, pallor, agitation, and
dizziness [80]. Cross-interactions of epinephrine with beta adrenergic blocker
medicine is known and therefore interference with intrinsic compensatory
responses to hypotension occurs [80].
Several routes of administration of epinephrine into patients are practiced in
the medical community such as intramuscular, intravenous, and inhalation.
Though the intramuscular route is the most used, some medical professionals
recommend an inhalation route or an intravenous route for unresponsive patients
[80]. Though there is a lack of comparative study on different routes due to inability
of conducting research on anaphylactic patients. In this work, epinephrine samples
studied are collected from EAIs which were intended only for use through
intramuscular route.

1.2.4 Epinephrine measurement by UHPLC
The drug formula for commercial EAIs contain several inactive ingredients
along with epinephrine. According to the product literature of EpiPen, the inactive
ingredients are sodium chloride, sodium metabisulfite, hydrochloric acid, and
water. Due to degradation and discoloration, several other melanin-like
compounds form in the solution [83, 84]. To measure epinephrine in such complex
solution, separation-based quantification method can be successful. To determine
the available dose of epinephrine, the analyte must be separated from the
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degraded compounds and other inactive ingredients. Consequently, reverse
phase liquid chromatography was chosen as a functional quantification technique
to measure available epinephrine dose in expired and degraded EAIs.
In liquid chromatography, a column packed with solid particles as stationary
phase and a liquid flow through the column as mobile phase are used. In reverse
phase liquid chromatography, the stationary phase particles are hydrophobic. The
mobile phase used is a purely hydrophilic liquid or a mixture of both hydrophilic
and hydrophobic liquids. The percent composition of the mobile phase can be
manipulated to control the elution profile and achieve better separation of the
analytes. The sample containing the desired analyte is injected to the column along
with the stream of the mobile phase. The analyte will be adsorbed by the stationary
phase particles along with the other compounds in the sample. By continuing the
flow of the mobile phase and changing the polarity of the mobile phase, all the
adsorbed molecules will elute the column based on the polarity. The more polar
molecules will elute faster because of less interaction with the hydrophobic
stationary phase and the less polar molecules will elute slower because of more
interaction with the hydrophobic stationary phase. Decreasing the polarity reduces
the analyte-stationary phase interaction, and as a result also aids the elution of the
less polar molecules. The elution time also depends on the particle size and the
pore size of the particles. The basic principle of the reverse phase liquid
chromatography is depicted in Figure 10.
The efficiency of chromatographic separation is dependent on the resolving
power of the column. Number of theoretical plates are correlated with the column
resolving power. Theoretical plates are hypothetical zones in a chromatographic
column where different phases are in equilibrium with each other. The resolving
power of a column is proportionally related with the number of theoretical plates.
Number of theoretical plates can be calculated using equation 2.
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Figure 10: Reverse phase liquid chromatography
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Here, N is the number of theoretical plates, L is the length of the column, and
H is the is the height of the theoretical plates. H can be calculated using the Van
Deemter equation (3).
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Here, λ is particle shape, dp is particle diameter, γ, ω, and R are constants, Dm
is diffusion co-efficient of the mobile phase, df is the film thickness, Ds is the
diffusion co-efficient of the stationary phase, and u is the linear velocity. According
to the Van Deemter equation, the resolving power of the column can be increased
by reducing the stationary phase particle size. However, the back pressure in the
column significantly increases due to decrease in particle size. Therefore, to
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enable using smaller particle for improved resolving power, UHPLC can be an
alternative for conventional HPLC. UHPLC systems possess modified pumping
facility to exert higher pressure to overcome the back pressure of the column due
to smaller particles.
Resolution can be defined as the matric of how distinguishable two
chromatographic peaks are resolved from each other. The resolution of a
chromatographic separation can be described by fundamental chromatographic
mechanisms via the fundamental resolution equation, equation 4.
𝑅𝑠 =

1
𝛼−1
𝑘
×
√𝑁 ×
4
𝛼
1+𝑘

4

Here, Rs is resolution, N is the number of theoretical plates, α is selectivity and
k is the retention factor. k is a function of retention time (t) and α is the ratio of
retention time of two separate peaks. Getting better resolution is a trade-off with
analysis time. Increase in number of theoretical plates, better selectivity and longer
retention time improve resolution at the expense of longer analysis time.
To establish the elution time of epinephrine under a certain method, pure
epinephrine standard solutions need to be injected. Same elution profile of pure
epinephrine at different concentrations can undoubtably establish the elution time.
By carefully selecting the concentration range of the pure epinephrine standards,
a calibration curve can be established. The calibration curve can be used to
estimate the available epinephrine in the EAI samples.

1.2.5 Quantitative smartphone imaging
Smartphone imaging has offered a variety of point-of-care applications since it has
emerged. All modern smartphones are equipped with a digital camera to capture
still and motion pictures without using any films. Almost all smartphone camera
has a CMOS sensor to process the light irradiated on it. CMOS stands for
complementary symmetry metal oxide semiconductor.
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Figure 11: Quantitative image analysis through RGB stacking

Each pixel is equipped with the charge to voltage converter and voltage
amplification systems. Light passes through the lens of the digital camera and
irradiates the pixels on the CMOS sensor. Light received by each pixel generates
proportional amount of charge which is converted to voltage. A voltage amplifier
inside each pixel amplifies the voltage before transferring to the readout meter.
A Bayer filter is an array used in typical CMOS sensors for placing red, green,
and blue color filters on square array of photosites [85]. The filter array is a
combination of 25% red layer, 50% green layer, and 25% blue layer. A single pixel
is aligned with only one of the filter layers. Therefore, the true color of a single pixel
cannot be inferred from the raw data. Demosaicing algorithms are used to assign
red, green, and blue component values of each pixel. Each of the components has
a value range from 0 to 255 in a typical 8-bit system. The value of each color
component is combined to portray a compound color. If a pixel is exposed to no
light, all three components will have a value of 0. If a pixel is exposed to white light,
all three components will have a value of 255. Any other color will have a
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combination of values within the range depending on the pixel being exposed to a
color of light. This image processing technique can be utilized to conduct
quantitative study on colored samples. If a sample contains a certain molecule or
impurity which is responsible for the color it possesses, then analyzing the color
pattern may be correlated with the concentration of the colored substance.
In this study, 23 expired and degraded EAIs have been investigated for
available dosage of epinephrine. Most of the samples had discoloration due to the
degradation and pure epinephrine drug appears as a clear solution. The increment
of the discoloration is hypothesized to be an indicator of the available epinephrine
in the solution. In Figure 11, an image of an EAI sample is shown. The image has
been disintegrated to its RGB components. Since the discoloration due
degradation in the samples exerts a brownish color, the sample should highly
absorb the colors of the blue end of the visible spectrum and reflect the colors of
the red end of the visible spectrum. Therefore, if the values of the blue component
are considered and correlated with the epinephrine concentration of the samples,
a calibration curve can be established and utilized to estimate the epinephrine
concentration of unknown samples.
Smartphones are a nearly ubiquitous technology in the modern world.
Therefore, using a smartphone camera for quantitative analysis of life-saving drugs
in austere situations can be an easily accessible alternative to complex and
expensive techniques. Using a smartphone as a quantitative analysis tool also
makes the process portable and robust. The functionality of a modern smartphone
perfectly aligns with the motivation of this study and achieves the analytical goal
of the study.

1.2.6 Summary
Background concepts regarding to our point-of-care epinephrine estimation
method are discussed in this section. The section includes brief discussion about
anaphylaxis indicating the symptoms, mechanism, and treatments. Brief
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discussions about measuring epinephrine through conventional HPLC and
alternate quantitative point-of-care method are also included in this section.

1.3 SCXC based immunoassay
1.3.1 Objective
The U.S. Centers for Disease Control reported a 29% increase in the
prevalence of Autism Spectrum Disorder (ASD) among 8-year-old children from
2008 to 2012 [86]. ASD affected children suffer from impaired social, emotional
and language development. The dynamic secretion of oxytocin in the
hypothalamus is strongly correlated with the development and expression of these
characteristics, and endogenous opioid peptides, such as β-endorphin, are known
to have a complex regulatory relationship with oxytocin secretion. There is a lack
of knowledge of the secretion dynamics of these hormones which prevents an
accurate understanding of the regulatory relationship between oxytocin and βendorphin. To facilitate the study of their secretion dynamics, new bioanalytical
assays are needed to enable the measurement of these hormones at low
concentrations in small volumes. This capability will enable the study of hormone
secretions at biologically relevant concentrations (high pM to low nM) and with
spatial resolution via ex-vivo slice culture.
The working hypothesis for this project is that SCXC can improve the
separations required for direct homogeneous immunoassays. To test this
hypothesis, immunoaffinity reaction between antigen (oxytocin or β-endorphin)
and a fluorescently labeled antibody will be carried out and the immunocomplex
will be crosslinked. SCXC separation of the crosslinked complex from unbound
antibody will be carried out to quantify oxytocin and β-endorphin in complex sample
matrices. Completing this project will enable a novel non-competitive
immunoassay technique using SCXC to quantify low concentrations of proteins
and peptides.
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1.3.2 Regulatory relationship between oxytocin and
β-endorphin
Oxytocin is a neuropeptide produced in the paraventricular and supraoptic
nuclei of the hypothalamus. It is dispersed in the bloodstream though the axon
termini of the posterior pituitary gland [87]. Oxytocin secretion has long been
known to be correlated with contraction of the uterus during childbirth and supply
of milk afterwards [88]. Later, dysregulation of oxytocin was suggested to be
responsible for expression of repetitive and affiliative behaviors which are
dominant features of Autism Spectrum Disorder (ASD) [88, 89]. β-endorphin is a
neurotransmitter secreted from the pituitary gland. It is known to act as an
endogenous analgesic, and is secreted in high amounts during stressful events
[90]. Opioid peptides like β-endorphin have regulatory relationships with oxytocin
secretion which weaken during stressed situations and differ in regulations while
observed in bovine and rodent plasma [91]. β-endorphin may play a role in the
pathology of ASD by dysregulation of the secretion of oxytocin, which may lead to
repetitive and affiliative behaviors observed in ASD. To better understand the
regulatory relationships of β-endorphin and oxytocin, new tools are needed for
modeling their secretion and measuring their concentrations in biologically relevant
yet well controlled in vitro conditions.

1.3.3 Immunoassays for peptide measurements
Immunoassays exploit the specific binding of antibodies to their antigen to
achieve high specificity detection of the antigen molecule. Thus, they are excellent
tools to quantify a specific molecule within a complex biological sample matrix. In
enzyme-linked immunosorbent assays (ELISA), antigens are bound to enzymelabeled antibodies where the enzyme activity, typically a detectable color or
luminescence change during reaction of a substrate with the enzyme, is measured
to determine the concentration of the antigen. ELISA was reported to measure
plasma oxytocin to correlate it to autism and found at lower levels in affected
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patients than controls [92]. Radioimmunoassay (RIA) work similarly to ELISA, but
they employ radiolabeling and scintillation counting as a detection mode. RIA has
been used to quantify plasma oxytocin levels, which were found to be higher in
schizophrenic patients as compared to control patients [93]. Immunoassays
performed using capillary electrophoresis (CE) were first reported in 1991 by
Nielsen et al [94]. Capillary electrophoresis-based Immunoassays (CE-IA) offer
fast measurements with ability to work with small sample volumes (low nL)
presenting the opportunity for automated microfluidic CE-IA platforms. In the most
common case, in which samples are collected via low flow rate techniques like
microdialysis, the larger sample volumes (100s µL) and slower measurements
(hours) required for ELISA and RIA make CE-IA a better choice when temporal
resolution of the measurement is critical. In CE-IA, mixtures of antibody and
antigen are injected into a fused silica capillary and separated based on their
electrophoretic mobility under applied voltage. Both competitive and noncompetitive Capillary Electrophoresis based Immunoassay (CE-IA) were
successfully demonstrated by Schultz and Kennedy in 1993 [95]. In noncompetitive
immunoassays, fluorescently labelled antibodies specific for the analyte of interest
are introduced in excess to the sample to achieve maximum binding. Increased
concentrations of analyte in the sample increases the amount of antibody-analyte
complex formed which is ideally observed as a resolved peak in the CE
electropherogram. Noncompetitive CE-IA has been applied to measure Bovine
Serum Albumin (BSA) with a limit of detection of 5nM [96]. Since CE separates
charged species based on size-to-charge ratio, obtaining desired resolution of
antibody and antibody-analyte complex can be difficult when they are very similar
in size. In competitive immunoassays, a fluorescently labelled antigen reagent is
added to compete for antibody binding with unlabeled antigen (the analyte) present
in the sample. Increased analyte concentration decreases the ratio of bound-tofree labeled antigen, observed as the ratio of two resolved peaks in the
electropherogram. Clenbuterol was successfully measured by competitive CE-IA
with a limit of detection of 2.5nM [97]. Competitive CE-IA overcomes the resolution
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challenge of non-competitive CE-IA as the complex-bound and free labeled
antigen will be significantly different in size. This resolution advantage comes at
the cost of detection sensitivity, since in non-competitive CE-IA the fluorescently
labeled antibody can be present in excess, whereas in competitive CE-IA
concentrations of antibody and antigen must be on the order of the dissociation
constant of the antibody-antigen complex to maintain equilibrium conditions
necessary for binding competition. To improve the analytical performance of
separations-based immunoassays, new approaches are needed that enable the
high sensitivity of non-competitive immunoassays while overcoming the resolution
limitation of non-competitive CE-IA.

1.3.4 Analytical challenge for conventional
immunoassays
Capillary Electrophoresis Immunoassay offer two different modes to measure
peptide hormones: non-competitive and competitive immunoassay. In noncompetitive CEIA, a fluorescently labeled antibody is introduced to the sample to
bind with the analyte of interest. When an immunocomplex of the labeled antibody
and analyte forms, the sample is injected to the capillary to separate the labeled
antibody from the immunocomplex based on the different electrophoretic mobility
of the species. The analytes of interest of this experiment are oxytocin and βendorphin. The molecular weight of these peptide hormones are 1 kDa and 3.5
kDa respectively. The molecular weight of the antibodies used in these
immunoassays are approximately 150 kDa. A successful non-competitive CEIA of
the analyte molecules will require separation of 150 kDa antibody and 151
kDa/153.5 kDa immunocomplex because only these are fluorescently detectable.
Separation of such similarly sized molecules by capillary electrophoresis with
desired resolution is very difficult [98]. An alternative way to measure peptide
hormones through CEIA is the competitive mode. In competitive immunoassay,
fluorescently labeled analyte-analog will be introduced to the sample in addition to
an unlabeled antibody. The labelled analyte molecules are expected to compete
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with the unlabeled analyte molecules from the sample to bind with the antibody. A
successful competitive CEIA of the analyte molecules will require separation of
151 kDa/153.5 kDa immunocomplex and 1 kDa/3.5 kDa analyte-analog because
only these are fluorescently detectable. So, competitive CEIA is effective to
improve the separation challenge faced with non-competitive CEIA. But,
competitive CEIA has two major drawbacks. First, to ensure the binding
competition, appropriate concentrations of labeled antigen and analyte

are

essential which need to be in the same order of magnitude as the dissociation
constant (KD) of the antibody [99]. If the concentrations are significantly lower than
the KD of the antibody, the binding competition will be insufficient, and the
equilibrium will not yield sufficient detectable free labeled analyte to deliver
quantitative information of the sample analyte. Second, fluorescently labelling
analyte may sterically hinder antibody-analyte interaction. Steric hindrance of
antibody binding is specially challenging when the analyte molecule is as small as
oxytocin. Non-competitive immunoassay can be useful for measuring low
concentration analyte by increasing the concentration of the antibody to shift the
equilibrium towards immunocomplex formation. To overcome the separation
challenge of CEIA, new competitive immunoassay format involving ultra-highperformance liquid chromatography (UHPLC) in strong cation exchange (SCX)
mode will be developed for oxytocin and β-endorphin.

1.3.5 Principles of ion exchange chromatography
Ion exchange chromatography (IEC) separates charged species based on their
interactions with oppositely charged stationary phase particles packed inside a
chromatography column. Analytes are eluted by a mobile phase gradient of
increasing concentration or varying pH, resulting in competition for stationary
phase binding sites or alteration of the charge on the molecule, respectively.
Cation exchange stationary phases are negatively charged and bind to positively
charged species, whereas anion exchange stationary phases are positively
charged and bind to negatively charged species. In general, ion exchange
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Figure 12: Schematic representation of binding and elution in SCXC
A. Injection of peptide mixture to a cation exchange column. The column has
negatively charged stationary phase. B. Positive peptides bind to stationary
phase; negative peptides remain non-retained. C. Negative peptides elute from
column while positive peptides remain bound. D. Positive peptides elute due to
the change of mobile phase profile (pH or Concentration change)

stationary phases are described as either “strong” or “weak” ion exchange
materials. Strong ion exchangers function over a wide range of pH but weak ion
exchangers alter their charge if pH falls out of a narrow tolerance range. pH
gradient ion exchange chromatography is a common tool for high efficiency
separation of protein mixtures in biological samples. For example, a mixture of
proteins (IgG, albumin, transferrin and anti Hep-B) in a sample were separated
using ion exchange chromatography by manipulating the pH of the elution buffer
according to the isoelectric point (pI) of the components [100]. Isoelectric point (pI)
is the pH value at which a molecule possesses no net charge, thus pH gradients
enable efficient elution of proteins by disrupting the ion-ion interaction of the protein
with the stationary phase. Importantly, the starting pH of the mobile phase must be
at least one pH unit below the pI of the molecule of interest to achieve efficient
binding of the protein to the stationary phase [101]. Method development for IEC
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includes choice of stationary phase, designing a suitable concentration or pH
gradient of the mobile phase, and optimizing mobile phase flow rate. IEC can be
employed for protein separations with exceptional resolution, for example the
separations of two protein molecules differing by a single charged amino acid unit
has been reported [102]. Importantly, IEC separations of high molecular weight
(~150kDa) monoclonal antibodies like IgG1 have resolved protein isoforms that
differ because of charge heterogeneity [103]. To facilitate faster and efficient
separation of protein complexes for non-competitive immunoassays, new IEC
methods specific to oxytocin and β-endorphin are needed.

1.3.6 Summary
Background concepts related to strong cation exchange-based immunoassay
of beta endorphin and oxytocin are discussed in this section. Brief descriptions of
typical analytical challenges of immunoassays and principle of strong cation
exchange-based chromatography are also included in this section.
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Chapter 2

2. Microfluidic brain slice culture via a novel bubble
perfusion device
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2.1 Abstract
Conventional brain slice culture techniques, such as rotary tube or membrane
interface culture, can maintain viable slice cultures over the course of days to
weeks, but these techniques are poorly suited for integration with perfusion
sampling. As a result, temporal analysis of cellular secretions using conventional
slice culture platforms is challenging. Here, we will discuss the development of a
microfluidic perfusion system that mimics the rotary tube technique by providing
alternating flows of liquid nutrients and carbogen gas. The system is based on
microfluidic bubble generation at a T-junction, in which perpendicular flows of
aqueous media and carbogen gas produces bubbles separated by liquid droplets
in a fashion similar to that of conventional microfluidic emulsion generators.
Characterization of flow conditions to control bubble/droplet frequency and volume
will be discussed. Challenges in achieving slice adhesion will be discussed, and
the characterization of a bio-compatible polysaccharide-based glue for slice
adhesion will be described. The system is designed for medium-to-long term
studies of slice culture biology lasting hours to days. Fluorescent calcium imaging
and PI/DAPI staining of cultured tissue slices of rodent hypothalamus are used to
confirm culture viability for medium-term temporal studies. The perfusion device
has potential for reagent flows downstream of the slice culture chamber, and the
application of segmented droplet flow for the temporally resolved analyses.
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2.2 Introduction
Ex vivo brain slice cultures are widely utilized model systems for studying
neurophysiology [1-3]. To prepare these models, living tissue slices containing
brain structures of interest are excised from donor animals and maintained in
environments that provide nutrient supply and waste removal sufficient to
substitute, at least temporarily, for the vascular perfusion no longer present in the
excised tissue. Neuronal tissues have a particularly high oxygen demand [4], thus
careful consideration is needed to design tissue culture systems that provide
appropriate oxygen supply. In the absence convection via vascular perfusion,
oxygen transport into the tissue occurs only by diffusion, therefore gaseous oxygen
delivery is most common as it takes advantage of higher rates of diffusion as
compared to oxygenated aqueous media.
An early design of a fluidic system for ex vivo slice culture is the rotary-tube
method [104], in which tissue slices are immobilized on a planar support and
placed in cell culture tube partially filled with culture media. The tube and planar
support assembly are slowly and continuously rotated about the central axis of the
tube, causing the immobilized tissue slice to be repeatedly submerged in media,
providing nutrient supply and waste removal, then emerged into the head space
of the tube, providing gaseous oxygen supply. While rotary tube methods are
particularly effective for long-term slice culture [104-110], the continuous motion of
the system limits the ability for long-term monitoring by microscopy or
electrophysiology. Membrane interface slice culture is an alternative approach that
is more amenable to integration with microscopy and electrophysiology [111-113].
By this method, tissue is maintained on a porous membrane at the interface of
aqueous media (below the membrane) and gaseous atmosphere (above the
membrane), receiving simultaneous nutrient and oxygen supply from opposite
faces of the tissue slice.
The emergence in recent years of research into “organ-on-chip” systems has
highlighted the value of ex vivo tissue culture for modeling complex relationships
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in systems biology [114-120]. A key feature to these systems is the culture of cells
and tissues in much smaller volumes of media, often with continuous perfusion, as
compared to conventional culture methods. Microfluidic systems enable precise
control of the culture environment, for modeling complex and dynamic biological
stimuli, and the collection of cellular secretions with minimal dilution, for
characterizing the response of these tissues to stimuli. The combination of precise
environmental control and high-fidelity characterization of cellular secretions in a
single microfluidic system can give insight into physiological phenomena difficult
or impossible to observe by other methods [121, 122]. Importantly, the focus on
secretion measurements in microfluidic organ-on-chip systems need not preclude
the integration of electrophysiology [19], and often the integration of microscopy
observations are greatly improved over conventional culture methods [123].
Roller tube and membrane interface culture methods utilize much larger media
volumes than microfluidic organ-on-chip systems, complicating secretion
measurements and motivating the design of microfluidic brain slice culture
platforms. In the microfluidic regime, designing for adequate oxygen delivery is a
unique challenge since flow systems are typically sealed, limiting access to
gaseous atmosphere. Rambani and co-workers developed a novel microfluidic
perfusion technique involving laminar interstitial flow of oxygenated aCSF to acute
brain slices maintaining viability for 5 days [21]. The technique was also successful
for removal of depleted medium and catabolites throughout the thickness of the
slice. Lam and co-workers have demonstrated the ability of controlling both spatial
and temporal variations of oxygen tension characteristic of in-vivo biology using
microfluidic techniques [124]. The method has potential to study the importance of
oxygen tension in the disease processes such as cancer, ischemic heart disease,
and wound healing.
Here, we present a new approach to microfluidic brain tissue slice culture
based on mimicking the alternating solution and gaseous oxygen delivery achieved
by roller tube methodologies. In this system, which we term a microfluidic “bubble
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perfusion” device, the principles of droplet microfluidics are employed to generate
droplets of culture media dispersed between bubbles of carbogen gas (95% O 2,
5% CO2), and brain tissue slices are perfused with the resulting monodisperse
droplets and bubbles. The present work focuses on demonstrating viability of
hypothalamic tissue in the microfluidic system for experiments lasting > 8 hours,
although the system has been designed with future applications to secretion
measurements in mind. System design and operation are discussed, fluidic
performance is characterized, and tissue health in the perfusion system is
demonstrated via Ca2+ imaging and propidium iodide (PI) staining.

2.3 Experimental procedure
2.3.1 Device fabrication
The device was a laminated glass/PDMS structure. 750 µm thick PDMS sheets
(Stockwell Elastomerics, Inc, Philadelphia, PA) were used as a channel layer.
Channels were designed using AutoCAD 2019 (AutoDesk, San Rafael, CA) and
cut using a CO2 direct-write laser cutter (VLS 2.3, Universal Laser Systems,
Scottsdale, AZ) to form a PDMS gasket. The PDMS gasket layer was plasma
bonded between two 75 x 25 mm microscope slides using a plasma cleaner (PDC001 HP, Harrick Plasma Inc., Ithaka, NY). Inlet and outlet holes were drilled on the
surface of the chip using a Dremel rotary tool fitted with a 1 mm diameter carbide
tipped bit. Luer ports (Cole Parmer, Vernon Hills, IL) were glued to form fluidic
connections at the inlet and outlet holes. The tissue chamber volume was formed
by cutting a gasket from clear VHB tape (McMaster Carr, Princeton, NJ). The VHB
gasket was attached to the glass surface of the device and sealed using a layer of
Gelbond film (Lonza Group LTD, Basel, Switzerland).

2.3.2 Characterization of carbogen bubble and aCSF
droplet
Carbogen gas (95% O2 and 5% CO2, Airgas, Knoxville, TN) and Earl’s
balanced salt solution (Sigma-Aldrich, Milwaukee, WI) were used as oxygen and
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nutrient supply, respectively. Carbogen gas was delivered to the device through
direct connection to the storage cylinder and culture media solution was delivered
to the chip using a syringe pump (New Era Pump Systems, Inc., Farmingdale, NY).
Droplet and bubble dimensions and frequency were characterized via smartphone
imaging using a Motorola G5S plus and digital image analysis using Fiji software
[125].

2.3.3 Synthesis of hydrogel glue
A two-part polysaccharide hydrogel glue was synthesized and used to ensure
tissue adhesion in the chamber. The synthesis protocol was followed as reported
by Balakrishnan and co-workers [56]. Briefly, 5 g Dextran (Fisher Scientific,
Suwanee, GA) dissolved in 100 mL Milli-Q purified water (Millipore, Bedford, MA)
was oxidized in the presence of sodium metaperiodate (Fisher Scientific,
Suwanee, GA) to dextran dialdehyde (DDA). The oxidation reaction was carried
out for 6 hours at room temperature in dark while constantly stirring the mixture.
The mixture was then dialyzed (MWCO = 12 KDa) for 48 hours to remove excess
sodium metaperiodate. The dialyzed solution was tested by reaction with 1 wt%
silver nitrate solution (Fisher Scientific, Suwanee, GA) and the lack of resulting
precipitate indicated adequate removal of sodium metaperiodate. The dialysate
was lyophilized and stored at 4 °C for future use. Chitosan hydrochloride (ChitHCl)
was synthesized following protocol described in Austin and Sennett [126]. 10 g
chitosan (Sigma-Aldrich, Milwaukee, WI) was continuously stirred in 60% ethanolic
HCl (Fisher Scientific, Suwanee, GA) for 3 hours at room temperature. The ChitHCl
product was filtered and washed thoroughly with 75% v/v acetone (Fisher
Scientific, Suwanee, GA). The residue was dialyzed (MWCO = 12 KDa) and the
absence of residual HCl was confirmed by 1 wt% silver nitrate. The dialysate was
lyophilized and stored at 4 °C for future use. To form the final two-part hydrogel
glue, separate 5 wt% ChitHCl and 10 wt% DDA solutions were prepared using
phosphate buffer saline (Fisher Scientific, Suwanee, GA). 2 µL of each solution
was mixed on the hydrophilic side of the Gelbond film immediately prior to placing
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a tissue slice on to the glue mixture. The tissue loaded Gelbond film was then used
to seal the perfusion chamber, as described above.

2.3.4 Tissue slice preparation and Fluo-4 AM dye
loading
500 µm thick coronal tissue sections containing the suprachiasmatic nucleus
(SCN), underlying optic chiasm, and a small area of surrounding anterior
hypothalamus were prepared from 2-4 month old male C57/Bl mice (Envigo,
Indianapolis, IN) that had been housed in 12:12 light-dark conditions with food
available ad libidium, as described previously [127]. Tissue slices were initially
placed in an interface brain slice chamber constantly perfused with EBSS (pH 7.4)
at a rate of approximately 25 mL h-1, maintained at 37oC, and supplied with
carbogen gas as described [127, 128]. The tissue was allowed to recover from the
trauma of slice preparation for 1 hour.
Tissue slices were submerged in 10 µM solution of Fluo-4 AM dye (Fisher
Scientific, Suwanee, GA) and 1% Pluronic acid-127 (Molecular Probes, Eugene,
OR). The Fluo-4 AM dye was diluted to the desired concentration using Earl’s
balanced salt solution (Sigma-Aldrich, Milwaukee, WI). Slices were kept
submerged in the dye-loading solution for 45 minutes, following the protocol
reported by Cameron and co-workers [64].

2.3.5 Perfusion experiment and calcium imaging setup
To maintain the uninterrupted supply of the carbogen gas to the device, a direct
connection between the storage cylinder and the device inlet was established. The
flowrate of the gas was regulated by a gas regulator connected to fused silica
capillary tubing (23 cm long, 25 µm I.D.) which provided appropriate back pressure
and allowed control of gas flow rates by applying pressures determined by the
Hagen-Poiseuille equation. The flowrate of the gaseous media was kept constant
at 38 µL min-1.
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Images of dye-loaded tissue slices were captured at fixed time interval by a
high-resolution monochrome CMOS camera (DCC3260M, Thorlabs, Newton, NJ)
using a lab-built epi-fluorescent microscope system. Illumination was via a 488 nm
laser diode (L488P60, Thorlabs, Newton, NJ) transmitted to the chamber via a 490
nm long pass dichroic mirror (DMLP490R, Thorlabs, Newton, NJ) and a 10X
microscope objective lens (Newport Corporation, Mountain View, CA). Emission
was collected by the same objective lens, then passed through a 515 +/- 5 nm
bandpass filter (FL514.5-10, Thorlabs, Newton, NJ) before the image was
captured by the camera. Images were processed and analyzed using Fiji [125].
The temperature of the chamber was regulated using a resistive heater powered
by a programmable controller (TC200, Thorlabs, Newton, NJ).

2.3.6 Propidium Iodide staining and fluorescence
imaging setup
To assess the tissue health in the perfusion system, the tissue slices were
subjected to propidium iodide (PI) staining [129-132]. PI is able to enter dead and
damaged cells due to reduced membrane integrity, after which it intercalates with
the DNA and fluoresces upon excitation with appropriate wavelength of light (535
nm). After Ca2+ imaging was complete, the tissue sections were perfused within
the microfluidic chamber for 2 h with 4.6 µg/ml PI (Fisher Scientific) prepared in
EBSS. The tissue slices were then removed from the microfluidic chamber and
transferred to a scintillation vial containing 4% PFA and incubated for 10 mins on
ice. After 10 mins, the PFA was replaced with a 30% sucrose solution, and the
tissue sections were incubated overnight in at 4ºC. The following day, the slices
were removed from the sucrose solution and embedded in optimal cutting
temperature compound (Fisher Scientific) and stored in -80º until sectioning. The
tissue slices were thin-cut (10 µm) with a cryostat and the sections were collected
on gelatin-subbed slides and stored in -80º to be processed further for staining.
For staining, the slides containing the tissue sections were first allowed to air dry
and then washed once in phosphate buffered saline for 10 mins. After the wash,
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the sections were coverslipped using mounting media that includes the nuclear
stain 4′,6-diamidino-2-phenylindole (DAPI; Vectashield, Vector Laboratories,
Burlingame, CA) and the edges were sealed using a nail-polish. Fluorescence
images were acquired using a Leica DM6000B microscope. The images were
analyzed using ImageJ software (NIH). Cell counts were performed on a single
tissue section, taken near the middle of the SCN, from each tissue section. The
images were split into blue and red channels, where the blue channel shows DAPIstained cells and the red channel shows PI-stained cells. The SCN region was
identified as a region of high cell density immediately dorsal to the optic chiasm.
The total number of cells in the identified area were counted using the blue
channel. The PI intensity across the cells in the same region was assessed using
the red channel. The number of high PI intensity cells corresponds to the number
of dead and damaged cells. The percent of dead/damaged cells was then
calculated as the ratio of high PI intensity cells to DAPI cells.

2.4 Results and Discussions
To enable a new mode of oxygen delivery in microfluidic brain slice culture, a
microfluidic device was developed to deliver alternating carbogen gas bubbles and
media droplets to a miniature tissue culture chamber. The top view of the
microfluidic device is shown in Figure 13a illustrating the inlets, outlet, the tissue
perfusion chamber. The carbogen bubbles and the media droplets perfused
through the tissue perfusion chamber providing oxygen and nutrients, respectively.
The perfusate droplets were collected via the outlet port. Figure 13b shows the
exploded view of the device. The channel containing PDMS layer was sandwiched
between two microscope slides. The tissue perfusion chamber was placed on the
top glass slide and sealed with the hydrophilic face of the GelBond film forming the
interior wall of the tissue chamber.
The generation of segmented carbogen bubbles and media droplets is
analogous to conventional droplet microfluidics techniques, albeit with a dispersing
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phase, in this case the carbogen gas, of particularly low viscosity [133]. It has been
shown that in similar microfluidic systems droplet and bubble dimensions are a
function of channel dimensions and the ratio of gas and liquid flow rates [42].

Figure 13: Novel microfluidic rodent brain slice culture device
a The top view of the slice culture chip showing i. carbogen inlet, ii. media inlet, iii.
outlet/fractionation collection, and iv. tissue perfusion chamber with a mock
agarose slice, b Exploded view of the slice culture chip showing the different
layers.
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In the present work, relatively large bubble, and droplet volumes, as compared
to conventional microfluidic dimensions, were needed to achieve well-controlled
perfusion behavior in the tissue chamber. Typical tissue slices were 0.5 mm thick
with lateral dimensions of ca. 1.5 x 1 mm. The chamber was designed to allow
convective flow around all exposed faces of the tissue slice, excluding the face
adhered to the chamber surface. Chamber depth was 0.75 mm and overall
chamber volume was ca. 6.75 μL. As a result, relatively large channel dimensions
(channel width 1.6 mm) at the droplet-forming intersection were needed, and
bubble/droplet formation was characterized at these channel dimensions (Figure
14).
To understand the precision with which bubble perfusion could be delivered to
tissue slices, we characterized multiple dimensions of bubble and droplet
generation. Bubble volume was characterized following the work of van Steijn and
coworkers [42]. They showed that at conventional microfluidic scales bubble
volume was well controlled via the ratio of volumetric flow rates for the gaseous
(qg) and liquid (ql) components. We observed the same trend at larger channel
dimensions in the current device (Figure 14a). The volume of both the bubbles and
the droplets followed the expected trend of increasing and decreasing respectively
with increasing qg at a constant ql(Figure 14b). A convenient approach for
describing total liquid perfusion volumes in a system delivering segmented flow is
to consider the duty cycle of liquid flow. Duty cycle of droplets was characterized
at a constant ql across various values of qg (Figure 14c) and was observed to
decreased linearly with increasing qg. Precise control of droplet duty cycle enables
perfusion of tissue slices with dynamic and highly reproducible perfusion volumes.
Another key consideration of perfusion dynamics was the frequency of droplet
generation, intended to ensure adequate oxygenation over hours-long perfusion
experiments. Bubble frequency increased linearly with qg (Figure 14d) which, along
with the observations of droplet duty cycle, suggested that droplet and bubble
dynamics resulted from laminar flow mechanisms as in conventional droplet
microfluidics, despite large channel dimensions and low viscosity of the gaseous
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Figure 14: Characterization of the novel microfluidic
rodent brain slice culture device
a The characterization of the length of the bubbles generated at the T-junction as
a function of the ration of the gas and liquid phase volumetric flowrates (R2 = 0.99),
b The characterization of the carbogen bubble volume (R2 = 0.91) and media
droplet volume (R2 = 0.87) as a function of the volumetric flowrate of the carbogen
gas, c the characterization of the duty cycle as a function of the volumetric flowrate
of the carbogen gas (R2 = 0.98), and d the characterization of the frequency of the
bubbles generated at the T-junction as a function of the volumetric flowrate of the
carbogen gas (R2 = 0.98).

dispersing phase. Importantly, at all values of qg evaluated here, observed bubble
frequencies exceeded those common for roller tube culture techniques (typ. 1 – 2
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gas emersions min-1), which was limited by the high droplet duty cycle that would
result at very low values of qg. All tissue perfusion experiments in the present work
were conducted at 50% droplet duty cycle (ca. 4.5 bubbles min-1) to mimic the
conditions of conventional roller tube tissue culture. The system provides
significantly higher temporal resolution than a conventional in-vivo micro-dialysis
technique which requires hours to accumulate enough sample for one
measurement [134]. Controlling duty cycle and bubble frequency may offer a
convenient mechanism to precisely model hyperoxia and hypoxia in tissue slice
cultures, which we intend to explore further in future work.
To model the pressure environment of a tissue perfusion experiment while
characterizing the bubble and droplet generation dynamics shown in Figure 14,
the tissue chamber was loaded with either non-viable tissue slices prepared from
frozen tissue or mock tissue slices prepared from 2% agarose gel. During these
experiments we observed two key design challenges relating to the tissue
chamber. First, slice immobilization within the tissue chamber was difficult to
achieve. Initially, slices were immobilized to the chamber wall using thrombincoagulated chicken plasma, which is a common technique utilized in roller tube
culture [135]. When immobilized via coagulated chicken plasma, slices became
dislodged from their mounted position and subsequently flushed into the flow
channel within 45 minutes of perfusion (Figure 15a). We attributed this to increased
shear forces as compared to those of a typical a roller tube experiment, and
therefore presumed that the adhesion forces provided by the coagulated chicken
plasma were insufficient. We investigated numerous approaches to immobilizing
the tissue slice via physical structures that held the slice in place, but in every case
the additional geometry within the chamber disrupted segmented flow. Although
cyanoacrylate-based adhesives offer appropriate holding force, studies have
shown poor cytocompatibility of these materials [136]. Ultimately, improved
adhesion was possible by synthesizing a bio-compatible hydrogel glue first
described by Balakrishnan and coworkers [56]. Details on the structure and
synthesis of this Chitosan/Dextran-based glue are given in the supporting
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Figure 15: Tissue adhesion
a Unsuccessful attempt of tissue adhesion using chicken plasma and thrombin
glue i. dislodged rodent brain slice, ii. Direction of flow, and iii. Original position of
the rodent brain slice b Demonstration of successful implementation of
polysaccharide-based hydrogel glue for tissue (shown in black rectangles) at i.
beginning of perfusion, ii. 1 hour, iii. 2 hours, and iv. 3 hours.
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information. Figure 15b shows a coronal cross section of a rodent hippocampus
adhered to the chamber for more than 3 hours of perfusion, indicating a dramatic
increase in adhesive performance as compared to thrombin-coagulated chicken
plasma. Utilizing the hydrogel glue, slices routinely adhered to the chamber for the
full duration of 10+ hour perfusion experiments with no observed indications of
failure or fatigue.
The second design challenge was that of maintaining monodisperse droplets
and bubbles as the flow entered the chamber, perfused the tissue slice, and exited
the chamber. This can also be observed in Figure 15b, in which bubbles of various
volume and generally poorly structured segmented flow is observed throughout
the chamber and across multiple time points. We deemed it a strict requirement to
maintain well-structured segmented flow over the tissue slice and in the effluent
exiting the tissue chamber for two reasons. First, ensuring that the full volume of
each droplet and bubble transited the chamber undisrupted was essential to
ensuring that droplet/bubble generation accurately described the volumes and
relative durations of perfusion conditions experienced by the tissue. Second,
maintaining segmented flow in the effluent of the tissue chamber will offer benefits
in future applications involving downstream temporal profiling of cellular
secretions. Droplet microfluidics have been shown to offer substantial advantages
for decoupling the timescales of analysis from those of perfusion [137, 138], and
we postulate that the same advantages can be achieved with this bubblesegmented system. We intend to demonstrate this capability in future work.
We observed irregularities in segmented flow through the tissue chamber of
two types which we termed “bubble sticking”, and “droplet coalescence”. Bubble
sticking referred to the tendency for small fractions of a bubble to break apart from
the main bubble and remain trapped within the chamber, often in contact with the
tissue slice. This phenomenon can be observed in Figure 15b panels ii – iv. In this
case, bubbles were typically trapped for the duration of the perfusion experiment,
even as further droplets and bubbles perfused around the trapped bubble. This
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was not ideal for well controlled perfusion because the trapped bubble represented
a barrier to transporting fresh oxygen and media to the adjacent region of tissue.
Droplet coalescence occurred when a full oxygen bubble was observed to remain
stagnant within the chamber while two or more droplets appeared to flow around
the bubble via the wetted outer perimeter of the tissue chamber. In these cases,
the problem typically persisted for several droplets before the trapped bubble was
cleared by a subsequent bubble or droplet. When present, the phenomenon would
typically recur in an irregular and chaotic manner for the duration of a perfusion
experiment.
Although no quantitative metrics were observed by which these irregular flow
phenomena could be predicted or controlled, we did develop best design practices
that effectively eliminated their occurrence. First, the use of hydrophilic materials
within the tissue chamber was essential. This motivated the construction of the
tissue chamber from VHB adhesive and GelBond film rather than conventional
materials such as PMMA or PDMS. Second, droplet and bubble volumes greater
than 50% of the chamber volume were effective at reducing both types of flow
irregularities. Finally, the geometry of the chamber, and especially the transitional
from flow channel to chamber, had a dramatic impact on the occurrence of these
flow phenomena. We anticipated that a gradual, sloping transition from the narrow
flow channel to the wider tissue chamber would produce the least disruption at the
gas-liquid interface and thereby help maintain segmented flow. Interestingly, we
observed that the exact opposite was true. Flow irregularities were dramatically
reduced or eliminated in chamber designs that included an abrupt transition from
channel width to chamber width (as shown in Figure 13a), as opposed to those
with gradual transitions (as shown in Figure 15b). Further work is needed to
elucidate the precise relationship between chamber design parameters and the
ability to maintain segmented flow throughout the perfusion experiment. This is
especially important considering that various brain slice preparations will require
different chamber dimensions and volumes. In future work, we intend to
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Figure 16: Fluorescence calcium imaging
a Schematic of the epifluorescence instrument setup for Ca2+ imaging for SCN
slice viability. The image of an SCN slice is shown in the black rectangle and b the
response of the SCN slice through Ca2+ induced fluorescence of Fluo-4 AM dye
due to KCl stimuli.
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characterize these relationships and optimize chamber design for a range of
common slice preparations.
To demonstrate the utility of this microfluidic system for maintaining healthy model
tissue, slices of murine hypothalamus containing the suprachiasmatic nucleus
(SCN) were loaded with the calcium-sensitive fluorescent dye Fluo-4 before
perfusion within the device for 8 – 10 hours. Calcium transients were induced in
the SCN tissue by delivering a depolarizing stimulus of 30 mM KCl in culture
medium, and fluorescence imaging was conducted via the instrumentation
illustrated in Figure 16a. ImageJ was used to define a region of interest that
included only SCN tissue, and grayscale value was recorded as relative
fluorescence intensity. KCL stimuli were delivered as 32 µL injections every 30
mins, and the concentration profile of stimulus delivery was characterized prior to
perfusion experiments using fluorescent dye injections (see appendix A, Figure
32). Figure 16b shows a representative plot of relative Fluo-4 fluorescence vs.
time, indicating strong calcium influxes correlated with the timing of KCl stimulus
delivery. These robust calcium responses give qualitative indication that tissue
remained viable in the perfusion system for the duration of perfusion experiments
lasting typically 8 – 10 hours. We observed a high rate of success in maintaining
viable tissue in the perfusion system, with 80% of the experiments (ntotal = 5, nviable
= 4) showing robust calcium response for the duration of perfusion. Tissue that
failed to show robust calcium response could, in many cases, be attributed to
prolonged handling time during the dye loading step or while mounting the tissue
in the chamber.
To compare viable to non-viable perfusion experiments in a semi-quantitative
manner, we conducted propidium iodide/DAPI co-staining on representative tissue
samples that showed no calcium and robust calcium responses (Figure 17a and
Figure 17b respectively). The circled regions represent SCN tissue, blue
represents nuclei stained with DAPI, and dead cells are stained pink by propidium
iodide. Based on digital image processing using ImageJ, the non-viable tissue
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Figure 17: PI/DAPI staining
Fluorescent micrographs of DAPI/PI co-stained hypothalamic tissue slices after 8
– 10 hours of bubble perfusion. a Tissue for which no calcium transients were
observed b Tissue that demonstrated robust calcium response throughout the
perfusion experiment. Circles indicate the regions of analyzed as SCN tissue.
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shows approximately 25 dead cells for every 100 total cells within the SCN. For
tissue that showed robust calcium response, these numbers are approximately 7
dead cells for every 100 total cells. This study indicates that robust calcium
response in the SCN is likely correlated with overall cell viability in the region.

2.5 Conclusion
Microfluidic organ-on-chip technologies are emerging as valuable tools for
modeling complex biological systems under well-controlled conditions. The culture
of brain tissue slices in microfluidic systems presents unique challenges, including
that of providing adequate oxygen delivery. In the present work, a novel
microfluidic perfusion system for brain tissue slice culture was designed and
demonstrated. This system takes inspiration from both roller-tube tissue culture
methods and droplet microfluidic devices to perfuse tissue slices with well-defined
volumes of culture media and gaseous oxygen as monodisperse droplets and
bubbles.
Via calcium imaging and DAPI/propidium iodide co-staining, this work
demonstrated that the microfluidic perfusion system can maintain viable tissue
slices throughout perfusion experiments lasting 8 – 10 hours. Importantly, these
experiments were not limited by physiological concerns for the tissue, thus tissue
viability in the perfusion system may last longer than these durations. While this
work has demonstrated a novel system for tissue perfusion with unique operational
advantages, substantial work in this area remains. Tissue chamber design plays
an important and thus far poorly understood role in maintaining appropriate
segmented perfusion, and unique geometries are likely needed for various tissue
preparations. Importantly, the maintenance of segmented flow throughout
perfusion has unique advantages for tissue secretion measurements, but further
work is needed to demonstrate the utility of this system for such application. We
intend to address these in future work outlining the continued development of this
tissue perfusion platform. Still, this work represents an important proof-of-principle
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for droplet and bubble perfusion as a technique for providing appropriate nutrient
and oxygen delivery for brain tissue slices cultured in microfluidic volumes.
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3.1 Abstract

Figure 18: Graphical abstract of chapter 3

Epinephrine autoinjectors (EAIs) are important first aid medications for treating
anaphylaxis. A 10-fold price increase over the past 12 years, and evidence that
expired EAIs may still contain significant doses of available epinephrine, have
motivated interest in the efficacy of expired EAIs as treatments of last resort.
Degradation of expired EAIs, which can be caused by improper storage conditions,
results in various degrees of discoloration of the epinephrine solution. Previous
studies have determined that significant epinephrine remains available in expired
EAIs, but these have only considered EAIs that show no discoloration. Here, we
investigate the potential for colorimetric estimation of available epinephrine dose
based on the degree of discoloration in expired EAIs. The correlation of available
epinephrine dose and time since expiration date was poor (r = -0.37), as
determined by an industry standard UHPLC protocol. Visible absorbance of the
samples integrated across the range 430 - 475 nm correlated well with available
epinephrine dose (r = -0.71). This wavelength corresponds to the blue channel of
a typical smartphone camera Bayer filter. Smartphone camera images of the EAI
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solutions in various illumination conditions were analyzed to assign color indices
representing the degree of discoloration. Color index of the samples showed
similar correlation (|r| > 0.7) with available epinephrine dose as that of visible
spectrophotometry. Smartphone imaging colorimetry is proposed as a potential
point-of-use epinephrine dose estimator for expired and degraded EAIs.

3.2 Introduction
Epinephrine is widely used as a first aid drug for the treatment of anaphylaxis
[139, 140]. Anaphylaxis can be triggered by a wide variety of stimuli including food,
medication,

and

envenomation

[141-145].

Anaphylaxis

shows

signs of

hyperallergic reactions in quick successions and can lead to death [146, 147].
Epinephrine induces vasoconstriction which helps reduce or prevent upper airway
mucosal edema, hypotension, and shock. Epinephrine also has important
bronchodilator effects that help relieve laryngospasm and bronchospasm and
cardiac inotropic and chronotropic effects, which also helps in treating hypotension
and shock [146]. Fatality in cases of anaphylaxis is correlated with delayed
epinephrine administration [147]. Immediate recognition of anaphylaxis and ability
to administer epinephrine are vital to saving lives in cases of anaphylaxis, which is
why many people prone to severe allergic reaction, as well as first aid providers,
carry epinephrine autoinjectors (EAIs). Still, studies suggest that underuse of
epinephrine as a first aid drug in cases of anaphylaxis is a significant problem
[148].
EAIs typically contain 1 mg mL-1 epinephrine (0.5 mg mL-1 for EpiPen Junior)
in saline solution, and are marked with expiration dates after which administration
of the drug is not recommended [149]. Recent price increases of commercial EAIs
have triggered interest in the efficacy of expired EAIs. In 2007, average EAI price
increased 545% to $350 [66] and by 2016 the price was $600 [67]. A study on
patient compliance reported that even patients with high awareness of EAI
expiration date may still carry expired EAIs and delay replacement [68, 69].
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Several studies have found 50-90% active ingredient still available in EAIs from 190 months after their expiration dates [70, 150, 151].
Epinephrine oxidizes in the presence of atmospheric oxygen, taking on a pink
to brown appearance depending on the extent of oxidation [152]. Similar
degradation of EAI contents was observed after prolonged heat exposure [153].
In-depth study on effect of oxidation on drug degradation is absent because such
effects can be well managed via proper storage of drug containers by keeping
them away from light, heat, and atmospheric oxygen [154]. Additionally, drugs
susceptible to oxidation are often formulated with antioxidant agents. For example,
EAIs contain inert sodium metabisulfite which is a widely used antioxidant used in
numerous drugs [155]. Therefore, degradation of epinephrine in EAIs can be
attributed to poor storage conditions and prolonged exposure to light, heat, and
atmospheric oxygen. There is evidence to suggest that epinephrine degradation
products are well tolerated in the body. Ocular epinephrine drugs can cause
pigmentation of conjunctiva [156, 157] and cornea [84, 156-159] due to
epinephrine degradation products produced upon light exposure [160, 161]. The
oxidized derivative of epinephrine is melanin-like adrenochrome [83, 84], and the
resulting discoloration of the eye is tolerated as a side-effect of ocular epinephrine
drugs [161]. Although it is advised to not use discolored EAIs [70, 149, 150], the
prevalence of expired EAIs due to cost pressures, and the nature of epinephrine
as a drug of first aid, presents the possibility that expired and discolored EAIs can
be the only option available in emergency and remote settings.
Austere medicine is the practice of medicine in resource-constrained
environments, from wilderness areas in North America to third world countries
[162]. In austere environments the ability to procure fresh medicine can be
severely hampered, and the conundrum of using whatever medicine is available
becomes the issue. Epinephrine is a life-saving drug for patients experiencing
anaphylaxis and, if the medicine is discolored or out of date, waiting for
replacement epinephrine may not be a viable option. The safety and efficacy of
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expired and discolored EAIs is not well established, and the current accepted
practice is that discolored EAIs should not be administered. Still, austere medical
scenarios exist in which discolored medication will be administered, and in such
cases the ability to assess the concentration of epinephrine in discolored or expired
EAIs using ubiquitous and readily available smart phone technology may save
lives.
Simons and coworkers determined the available active ingredient in expired
EAIs [70]. 28 EpiPens and 6 EpiPen Juniors were investigated via
spectrophotometry and HPLC. Nearly all samples were colorless and free from
precipitates, and all contained at least 50% of the intended epinephrine dose. They
concluded that using an expired EAI during an emergency outweighs the potential
risk of giving no treatment, presuming no signs of degradation are observed [70,
163].

These studies did not consider extensively expired EAIs that showed

substantial degrees of discoloration.
Smartphone imaging is emerging as an approach to colorimetric detection for
quantitative analysis. Blood glucose concentration in diabetic patients [164],
electrolytes concentration in human sweat [165], and alkaline phosphate
concentration in dairy [166] and serum [167] samples have been quantified via
smartphone images. Smartphone imaging has also been utilized in applications
such as detecting nucleic acids [168], influenza virus counting[169], immunoassay
of prostate specific antigens [170], and detection of Hg2+ via smartphone
fluorescence microscopy [171-173].
We hypothesized that discolored EAIs present the opportunity for simple
colorimetric estimation of the available epinephrine dose by quantitative
smartphone imaging, which may facilitate the evaluation of EAIs at the point of
care. Here, we investigated expired EAIs showing various degrees of discoloration
with the objectives of 1) Determining the correlation between available epinephrine
and the time elapsed since expiration date; 2) Determining the correlation between
available epinephrine and the degree of discoloration; and 3) Developing a simple

61

colorimetric methodology that utilizes smartphone imaging to estimate available
epinephrine dose in discolored EAI solutions.

3.3 Experimental section
3.3.1 Reagents and materials
Epinephrine, methanol, 1-octanesulfonic acid, 1 mL polypropylene syringes,
and 0.22 µm nylon syringe filters were from Fisher Scientific (Suwanee, GA). All
aqueous solutions were prepared with 18.2 MΩ water from Milli-Q purification
system (Millipore, Bedford, MA). The Luna C18 chromatography column (50 x 4.6
mm, 5 µm particle size, 100 A0 pore size) was from Phenomenex Inc (Torrance,
CA).

3.3.2 Expired EAI samples
Multiple EAIs were obtained from various sources. Expired EAIs were
requested, without reference to storage, and it is assumed that most, if not all the
EAIs, were carried by patients or EMS in non-temperature-controlled
environments. After receipt of the EAIs, all syringe units were carefully removed
from their delivery unit, placed in sealed Falcon tubes, and stored at room
temperature until assayed. Researchers developing the protocols and analyzing
the epinephrine samples were blinded to the expiration date until after analysis.
These samples represent a real-world scenario of EAI storage rather than using
EAIs from controlled environments. Time since expiration date for all the EAIs
ranged from 12 to 207 months.

3.3.3 Epinephrine measurements by UHPLC
The samples were filtered through 0.22 µm nylon syringe filters to eliminate any
particulates. The filtrates were diluted to 20% of original concentration with 50%
methanol in water solution. Epinephrine concentrations were determined using an
Agilent 1290 infinity series (Agilent Technologies, Inc, Santa Clara, CA) Ultra-High
Pressure Liquid Chromatography (UHPLC) instrument equipped with a diode array
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detector following a US Pharmacopeia (USP) standard protocol [174]. Briefly,
isocratic elution was conducted on a C18 column at 1 mL min-1 with a mobile phase
of 1:1 Methanol:Water with 0.1% 1-octanesulfonic acid added as an ion pairing
agent. UV absorbance was recorded at 278 nm. Epinephrine standard solutions
were used to produce a calibration curve in the range from 0.01 – 1.00 mg mL-1.
The concentrations of epinephrine in EAI samples were determined by fitting the
resultant peak area to the best fit line of the calibration data.

3.3.4 Characterization by UV-Vis spectrophotometry
UV-Vis spectra of the EAI samples were obtained using a NanoDrop One
spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The absorbance
maximum of 278 nm for epinephrine was determined using epinephrine standard
solutions, and a calibration curve was constructed in the concentration range of
0.01 to 1.00 mg mL-1. EAI samples were diluted to 20% of original concentration
to fall within the calibration range. Epinephrine concentrations for expired EAI
samples were determined via absorbance at 278 nm by fitting to the best fit line of
the calibration data.

3.3.5 Quantitative smartphone imaging
Color index was defined as the integrated absorbance of the spectral region
430-475 nm, which corresponds to the blue bandpass component of a common
photographic Bayer filter [175]. Smartphone images of the EAI samples were
obtained with a Motorola G5S plus device. The Open Camera android application
(http://opencamera.org.uk) was used to hold white balance and exposure time
constant for all images taken under a particular lighting condition. EAI samples
were imaged within standard 1 mL polypropylene syringes in four different lighting
conditions: ambient sunlight, fluorescent office illumination with smartphone
flashlight, fluorescent office illumination without smartphone flashlight, and under
dark lab conditions while utilizing the smartphone flashlight.
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3.4 Results and discussion

Figure 19: Epinephrine quantitation by UHPLC
Representative chromatograms of a pure epinephrine standards, b expired EAI
sample that appeared black, c expired EAI sample that appeared brown, d expired
EAI sample that appeared pink, e expired EAI sample that appeared clear, and f
Poor correlation (r=-0.37) was observed for epinephrine concentration in expired
and discolored EAI samples vs. time elapsed since expiration date
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Twenty-three expired EAIs, ranging from 12 to 207 months past expiration date,
were characterized to determine available epinephrine dose. UHPLC analysis of
epinephrine standard solutions via a standardized USP protocol gave a peak at
2.86 ± 0.01 minutes (Figure 19a). The EAI samples were observed as a range of
colored solution from clear to black, and were qualitatively categorized into four
groups, Clear, Pink, Brown, and Black, based on their appearance to the naked
eye. Figure 19b, Figure 19c, Figure 19d , and Figure 19e shows representative
chromatograms of samples from each qualitative category. All samples showed a
peak at approximately 2.9 minutes, indicative of available epinephrine in the EAI
solution. Increasing color intensity correlated with an increase in additional peaks
eluting in the range of 1 – 2 minutes. We postulate that these additional peaks are
epinephrine degradation by-products, although further study is needed to identify
these constituents. EAI samples were evaluated by UHPLC in triplicate to yield
concentration determinations with RSD < 5% in all cases. In this study, epinephrine
concentrations in expired EAIs were found to be in the range of 0.05 – 1.43 mg
mL-1 (See appendix A, Table 3). Although it was unexpected to observe
epinephrine concentrations higher than the reported dose of 1 mg mL -1, and the
nature of this discrepancy is not immediately clear, this finding corroborates those
of Simons and coworkers who measured epinephrine concentrations as high as
1.19 mg mL-1 [70]. We found that time since expiration date was a poor predictor
of available epinephrine dose in discolored EAIs. Simons and coworkers found a
Pearson correlation coefficient (r) of -0.63 indicating moderate correlation between
available epinephrine dose and time since expiration date in expired EAIs that had
been stored appropriately to prevent sample discoloration and formation of
particulates [70]. For discolored EAI solutions, we observed poor correlation (r = 0.37) of available epinephrine dose with time since expiration date (Figure 19f).
As an initial investigation into the efficacy of photometry for EAI
characterizations, epinephrine concentrations were determined by UV-Vis
spectrophotometry of the same filtered EAI samples used for UHPLC
measurements. UV absorbance spectra are shown in Figure 20a for the same
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Figure 20: Epinephrine quantitation by UV spectrophotometry
a Representative UV absorbance spectrum of discolored EAI samples and an
epinephrine standard solution at 0.4 mg mL-1, b Comparison of epinephrine
concentrations determined by UV spectrophotometry vs. those determined by the
industry standard UHPLC protocol, and c Residual plot of epinephrine
concentrations of EAI samples from UV spectrophotometry vs concentrations
determined by UHPLC
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representative samples shown in Figure 19b through Figure 19e, with an additional
trace showing an epinephrine standard solution of concentration 0.4 mg mL-1. EAI
epinephrine concentrations were determined via calibration of UV absorbance at
278 nm.
Figure 20b shows the comparison of epinephrine concentrations determined
by UV spectrophotometry with those determined by the standard UHPLC protocol.
UV absorbance consistently overestimated epinephrine concentrations, which is
evident from the mostly positive residual values shown in the residual plot of Figure
20c. We hypothesize that the inaccuracy of UV-absorbance in determining
epinephrine concentration is a result of spectral overlap between degradation
products in solution and epinephrine, which is supported by the observation of nonepinephrine peaks in the chromatograms of degraded EAI samples with
absorbance detection at 278 nm (see Figure 19b through Figure 19e). Importantly,
UV-absorbance was measured using filtered samples, which eliminated particulate
matter and had the effect of reducing, although not eliminating entirely, the
intensity of discoloration as observed by the naked eye. Filtration was necessary
prior to UHPLC and was convenient for avoiding aberrant scatter in UV
absorbance measurements, but it poorly approximated the conditions of expired
EAI solutions at the point of use.
We hypothesized that colorimetry of the unfiltered, and thus more intensely
colored, expired EAI samples would yield a more effective correlation with
epinephrine concentration. Unfiltered samples appeared with various red hues
ranging from pink to dark brown, thus we investigated absorbance in the blue
region of the visible spectra. Figure 21a shows the UV-Visible spectra in the range
175 – 850 nm and an enlarged view of the range 430 - 475 nm (inset), which
corresponds with the typical bandpass range of the blue component of a Bayer
filter found in many digital cameras [176]. The trend of integrated absorbance
across the range 430 - 475 nm corresponded with the trend of discoloration
intensity, shown in Figure 21b, and with the trend of epinephrine concentrations as
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Figure 21: Visible Spectrophotometry of discolored EAI solutions
a Representative UV-Vis absorbance spectrum of discolored EAI samples, labeled
by epinephrine concentration determined via UHPLC. The inset shows a magnified
view of the visible spectra in the range 430-475 nm, and b Images of samples
represented in panel a. Color labels correspond to the line colors of panel a
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Figure 22: Relative color index vs. epinephrine concentration
Color index correlates well with epinephrine concentration as determined by
UHPLC, giving a Pearson correlation coefficient of r = -0.71
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determined by UHPLC (given in Figure 21a color legend), whereas absorbance at
278 nm did not show the same correlation with the trend of epinephrine
concentrations.
The integrated area of the absorbance spectrum from 430 nm to 475 nm was
calculated for each sample, and we termed this value the color index. All measured
color index values were normalized by dividing by the highest measured color
index to give the relative color index, which has a maximum possible value of 1.
Figure 22 shows the correlation between epinephrine concentration as determined
by UHPLC and the relative color index value. A significant negative correlation is
observed as characterized by a Pearson correlation coefficient of -0.71. This
negative correlation suggests that colorimetry of the unfiltered degraded EAI
samples may offer an effective approach for estimating epinephrine concentration.
To demonstrate the efficacy of smartphone imaging for colorimetric assay of
degraded EAIs, solutions were transferred into standard 1 mL polypropylene
syringes and imaged via smartphone camera. Imaging conditions were
standardized by utilizing a sheet of standard A4 printer paper as an imaging
background, and multiple illumination conditions were investigated.
Each colored image was decomposed into 3 grayscale images representing
the red, green, and blue components (i.e. converted to “RGB stack”) using the
open source imaging application Fiji [125]. Mean grayscale intensities from the
blue image channel in specific regions of interest were used to determine an
approximated color index value according to equation 5.
𝐶𝑜𝑙𝑜𝑟 𝑖𝑛𝑑𝑒𝑥 = 𝑙𝑜𝑔10

𝐼0
𝐼

5

where I0 is the mean grayscale intensity from a representative region of interest on
the white background, and I is the mean grayscale intensity from a representative
area of the syringe as indicated in Figure 23a through Figure 23d. This image
analysis was
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Figure 23: Quantitative smartphone imaging
of discolored EAI solutions
Representative images of EAI solutions illuminated via a ambient sunlight, b
fluorescent office illumination with smartphone flashlight, c fluorescent office
illumination without smartphone flashlight, and d dark ambient conditions with
smartphone flashlight illumination; Plots of relative color index vs. epinephrine
concentration under e ambient sunlight (r = -0.77), f fluorescent office illumination
with smartphone flashlights (r = -0.76), g fluorescent office illumination without
smartphone flashlights (r = -0.71), and h dark ambient conditions with smartphone
flashlight illumination (r = -0.71). Black circles in figures a-d indicate regions of
interest that gave mean intensity values for R, G, and B as indicated in each figure.
Note smaller regions of interest were used in panel b and d to avoid the effects of
glare on the syringe surface
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performed on images collected outdoors under ambient sunlight (Figure 23a and
Figure 23e), under fluorescent office illumination with the addition of smartphone
flashlight illumination Figure 23b and Figure 23f), under fluorescent office
illumination without the addition of smartphone flashlight illumination (Figure 23c
and Figure 23g), and under dark conditions while utilizing the smartphone flashlight
(Figure 23d and Figure 23h). As with the data shown in Figure 21, all calculated
color index values were normalized to the highest measured color index to give
relative color index. Under all illumination conditions, similar negative correlations
are observed between the measured color index and the epinephrine dose as
determined via the standard UHPLC protocol, with r ranging from -0.71 to -0.77.
Following the methodology of Watters, and coworkers [177], the calibration plots
in Figure 23e - h were each fitted with a 95% confidence band to estimate
confidence interval as a function of epinephrine concentration (see appendix A,
Figure 33). The estimated 95% confidence interval at 1 mg mL -1 epinephrine
ranged from ± 0.12 to ± 0.15 mg mL-1 for all lighting conditions studied here,
indicating that, dependent on lighting conditions, a 12 - 15% reduction in reported
epinephrine dose can be detected with 95% confidence. There are two important
points to note here. First, these calibrations are intended to demonstrate proof of
principle, and further calibration from a wider variety of sample sources is needed
to deliver an assay with clinical utility. Second, there are no empirical limits
established on effective epinephrine dose because epinephrine dosing for the
treatment of anaphylaxis is not based on empirical study of dose-response
relationship [178]. Therefore, no empirical metric exists by which to determine
whether the demonstrated assay performance is sufficient for clinical utility. Still,
in-date EAIs have been reported to contain in the range of 86% - 114% of stated
epinephrine dose [70] indicating that the current assay can determine epinephrine
dose degradation to within the accuracy of dosage of unexpired EAIs.
A quantitative smartphone imaging assay can enable colorimetric estimation of
epinephrine in environments where imaging conditions could be difficult to control.
Thus, we investigated the robustness of this assay to sample
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Figure 24: Influence of sample distance and orientation
on color index determinations
Color index values were determined for representative samples shown in Figure
21while varying a imaging distance, and b syringe orientation with respect to the
camera. All bars within each sample color were compared via paired two sample
two-tailed t-test, and statistically significant differences (p < 0.05) were observed
between the bars indicated with an asterisk (*).

position and orientation with respect to the smartphone camera (Figure 24). Four
representative samples of various hue (i.e. clear, pink, brown, and black in
appearance) were studied to determine the variation of color index as a function
of the syringe distance from the smart phone camera. We estimated that a natural
ergonomic range of camera-sample distance for handheld image acquisition was
15 - 45 cm, and images were recorded with the syringe placed at 7.5 cm
increments within that range. For all images, the white background was placed 3.8
cm behind the syringe, which we estimated as an appropriate distance to represent
a syringe and white paper background held in the same hand approximately oneto-two finger widths apart. Figure 24a shows small but statistically significant
differences in color index for the clear sample only when comparing images
recorded at 22.5 cm to those recorded at 37.5 cm (p = 0.007). Statistically
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significant differences were observed for the brown sample when comparing
images recorded at 30 cm to either those recorded at 15 cm (p = 0.002) or those
recorded at 45 cm (p = 0.01), but no other significant differences were observed in
the study of camera-sample distance. When color index values from all sample
distances were pooled for each sample color, RSD was 4.8%, 4.3%, 4.9%, and
2.9% for clear, pink, brown, and black samples, respectively. This result suggests
that, despite the small significant differences observed, the imaging assay is robust
to camera-sample distance in the range of 15 - 45 cm.
We estimated that an operator could reasonably approximate syringe
orientation to within ± 20° of vertical. Thus, to study the influence of syringe
orientation, we collected sample images with syringes oriented vertically, and with
20° of tilt in the plane of the image (i.e. left and right tilt) and out of the plane of the
image (i.e. forward and back tilt). There were no statistically significant differences
observed when comparing data from vertically oriented syringes with those tilted
left or right, within the plane of the image (data not shown). This is unsurprising,
since tilted orientation within the plane of the image does not affect the path length
of light from the white background through the volume of the syringe. Statistically
significant reductions in color index value (p < 0.005) were observed when
comparing syringes tilted forward (i.e. toward the camera) with either vertical or
backward tilted syringe images for the pink and brown samples only (Figure 24b).
The origin of this phenomenon is not immediately clear, but we do not attribute it
to increased path length which would increase the observed color index value.
When color index values from all sample orientations were pooled for each sample
color, RSD was 5.0%, 3.4 %, 4.3%, and 7.5% for clear, pink, brown, and black
samples, respectively. Thus, the assay is robust to sample orientation when the
syringe is oriented within ± 20° of vertical.

3.5 Conclusions
We investigated available epinephrine dose in expired and discolored EAIs via
the USP standard UHPLC methodology, spectrophotometry, and quantitative
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smartphone imaging. We found that time past expiration date is a poor predictor
of available epinephrine concentration when EAIs have degraded and become
discolored. Although spectrophotometry is employed for quality control in
commercial epinephrine production [179], UV absorbance at 278 nm did not
accurately estimate the epinephrine concentration in degraded EAIs, likely due to
the presence of degradation products with spectral overlap with epinephrine. In
discolored and unfiltered EAIs, visible absorbance in the range 430-475 nm
correlated well with available epinephrine concentration, which enabled the
development of a quantitative smartphone imaging protocol. A simple digital
image processing procedure utilizing smartphone images yielded a strong
correlation (|r| > 0.7) with epinephrine concentrations determined by standard
UHPLC protocols, and this strong correlation persisted under various lighting
conditions. Quantitative smartphone imaging was robust to moderate variations in
sample-camera

distance

and

sample

orientation,

yielding

color

index

determination with RSD ≤ 7.5% in all cases studied.
The present work stops short of providing a point-of-use analysis tool for
several important reasons. First, although our work demonstrates feasibility for
quantitative imaging in various lighting conditions, a universal calibration that is
normalized for illumination and white balance conditions is still needed. This
presents a multivariate challenge that will form the basis of future work in this area.
Second, although the digital image processing employed here is well within the
computational abilities of common smartphones, in the present work digital image
processing was accomplished offline using a personal computer. Substantial
development is needed to package the image processing tasks along with an
appropriate user interface into a simple-to-use smartphone application. Again, we
intend to address this challenge with future work. Finally, and most importantly, the
safety and efficacy of administering discolored EAI drugs is not well established.
Although we postulate that the tolerance of discolored degradation products in
ocular epinephrine drugs suggests low toxicity of the degradation products, this
determination requires consideration by the wider medical community and lies well
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beyond the scope of the present work. Still, the present work establishes two key
findings: 1) EAI discoloration can be utilized as an indicator for approximating
available epinephrine concentration; and 2) EAI discoloration is readily quantified
via a simple and robust smartphone imaging procedure.
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Chapter 4
4. Cation exchange chromatography of Oxytocin and
β-endorphin
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4.1 Method development for SCXC-based
immunoassay of β-endorphin
An appropriate SCXC method is essential to separate antibody and
immunocomplex for successful non-competitive immunoassay. The retention of
any molecule in a specific cation exchange column at constant temperature
depends on the following factors: pH of mobile phase, isoelectric point of the
molecule, concentration of mobile phase, and flow rate of mobile phase. The
particle size in the cation exchange column is 5 µm. All the experiments were
carried out at room temperature. The mobile phases used in the chromatographic
separation are phosphate buffers in the concentration range of 5 mM to 1000mM.
The isoelectric point of the IgG antibody is in the range of 6.6-7.2. At pH 6, the
antibody molecule has a net positive charge, but it is expected to elute earlier than
β-endorphin which has a much higher isoelectric point (9.9).

Figure 25: Cation Exchange Chromatograms: individual injections of
β-endorphin(i), IgG antibody(ii), and a mixture of these
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Table 1: The working method for separation of IgG antibody
Column

Agilent Bio SCX, non-porous, 2.1 x 50 mm, 5 µm, PEEK

Flowrate

0.35 ml/min

Mobile phases

A (phosphate buffer, pH 6, 5.5 mM) and B (phosphate
buffer, pH 6, 1000 mM)

Mobile phase

0-2 min – 0% B, 2-17 min – 0%-50% B

gradient
Detection

214 nm

wavelength
Runtime

17 mins

Higher concentration of mobile phase A can make the IgG antibody possess a
very short retention time making it practically non-retained in the column. Large
number of particles in higher concentration mobile phase competes with the bound
molecule vigorously for early elution. 20mM or higher concentration of mobile
phase A made the IgG antibody elute earlier than 0.2 minute while even poorly
retained molecules should elute after 0.3 minute based on the void volume of the
column. 5.5mM concentration of mobile phase A allowed the IgG antibody to be
retained in the column and elute at around 0.5 min. The separation of the antibody
and analyte proved to be successful using a working method identified by trial and
error. Table 1 shows the working method used to obtain the chromatograms in
Figure 25.
Optimum flowrate maximizes separation efficiency in liquid chromatography by
minimizing the height equivalent to theoretical plates (HETP). HETP can be
expressed by the Van Deemter equation (6):

𝐻𝐸𝑇𝑃 = 𝐴 +
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𝐵
+ 𝐶𝑢
𝑢

6

Figure 26: Flowrate optimization

Here, A is the multiple paths term, B is the longitudinal diffusion term, C is mass
transfer term, u is mobile phase flowrate. Higher flowrate improves the longitudinal
diffusion term in the column but negatively affects the mass transfer term from
mobile and stationary phase. To identify a suitable flowrate for antibody separation,
a series of experiments were carried out following the method mentioned in Table
1. The flowrate of the experiments was decreased gradually from 0.35 ml/min to
0.05 ml/min and HETP was minimum at 0.10 ml/min. Figure 26 shows the change
of HETP with the change of flowrate.
When an immunomixture of β-endorphin and IgG antibody is injected, it is
expected that the analyte will bind to the specific binding site of the IgG antibody
and possess a different elution time from both the analyte and the antibody. The
immunocomplex is expected to elute at an intermediary time to β-endorphin and
IgG antibody retention time based on the following: when antibody binds to the
analyte, it is likely to block solvent access to one or more (but not likely all) cationic
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residues of β-endorphin. It is less likely that β-endorphin (3.5 kDa) blocks the
majority cationic residues of IgG antibody (150 kDa) because of the difference in
their molecular size. If the immunocomplex has formed without the species
blocking each other’s cationic residue, it is expected to elute slightly later than βendorphin. This assumption is based on the summation of the cationic character
of the strongly cationic β-endorphin and weakly cationic IgG antibody. Figure 25(iii)
shows a chromatogram of the injection of immunomixture of 10:1 molar ratio of βendorphin and IgG antibody. It does not show any unique migration time of any
new species other than β-endorphin and IgG antibody. Based on the evidence, it
can be hypothesized that the immunocomplex cannot withstand the stringency of
UHPLC-SCXC separations resulting rapid dissociation. A solution to overcome this
challenge can be introduction of covalent cross-linking of antigen to antibody to
use UHPLC-SCXC as a separation tool for non-competitive immunoassay of βendorphin.

4.2 Crosslinking of β-endorphin to IgG antibody for
covalent stabilization
Crosslinking stabilizes a non-covalent complex by introducing covalent bonds
formed between the proteins with a suitable linking reagent. Such reagents
possess two different reactive functional groups in their structure specific for
different functional groups in the two proteins to be crosslinked. β-endorphin
sequence has 5 lysine amino acids which contain primary amine functional groups.
IgG antibodies have cysteine residues forming di-sulfide bonds to retain the
structure of relatively large and high molecular weight molecule. Free sulfhydryl
functional group are also found in the variable domain of the light chain of IgG
antibody [180]. Since there are no sulfhydryl functional group in β-endorphin, it is
convenient to use amine-sulfhydryl crosslinking reagent for β-endorphin and IgG
antibody mixture to avoid intra-crosslinking in the analyte molecule. The
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Figure 27: Crosslinking of IgG antibody and antigen complex with
amine-sulfhydryl crosslinking reagent (Sulfo-GMBS or Sulfo-SMPB).

crosslinking procedure involves amine-sulfhydryl crosslinking reagent like SulfoSMPB or Sulfo-GMBS (structures in Figure 27). Both of the crosslinking reagents
contain sulfo-N hydroxysuccinimide ester (Sulfo-NHS ester) and maleimide
functional groups on either ends. Sulfo-NHS ester can conjugate with primary
amines available in the Lysine amino acids in beta-endorphin by forming amide
bonds. In physiological pH conditions (slightly alkaline, ~7.5), stable amide bonds
form between primary amines and Sulfo-NHS ester groups by releasing sulfoNHS. In similar physiological pH conditions, maleimide groups can conjugate with
sulfhydryl groups available in variable domain of the light chain of the IgG antibody
by forming stable thioether linkage. The spacer arm lengths of these crosslinking
reagents are 11.6 Å and 7.3 Å respectively. First, the amine containing protein (βendorphin) is solvated in pH 7.0 phosphate buffer saline. Then, the aminesulfhydryl crosslinking reagent is added at least 10-fold molar in excess to ensure
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binding with the amine containing protein. Excess crosslinker molecules are
separated from the mixture by desalting column using size exclusion principle.
Next, the sulfhydryl containing protein (IgG antibody) is added at the desired
concentration to the mixture to complete the crosslinking.

4.3 Minimization of equilibration time
Strong cation exchange columns require column equilibration between
experiments to carry out efficient separation. This limits the speed of the assay
which has an impact to the overall success of the aim. One of the integral parts of
aim 1 is to innovate rapid measurements of oxytocin and β-endorphin. Longer
column equilibration period will increase time delay between experiments making
the overall process slower than desired. The column equilibration period can be
shortened by utilizing the features of UHPLC, for example rapid flow rates and
gradient conditions. The Bio-SCX column used in the experiments has a
recommended column equilibration period of 30-45 minutes. The equilibration
period has been decreased to 15 minutes while providing similar separation
efficiency and resolution. Both IgG antibody and β-endorphin had similar retention
time in SCXC separation after 15 and 45-minute column equilibration. IgG antibody

Figure 28: SCXC separation of immunomixture
(β-endorphin and IgG antibody)
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and β-endorphin eluted at ca. 0.5 min and ca. 6.5 min respectively in both
experiments with different equilibration period (Figure 28).
The equilibration period may further be decreased by faster flowrates and
steeper mobile phase gradient. following the same protocol. In the scenario of not
being able to have shorter equilibration period of the column to obtain desired
separation speed, instrument modification may be done to add another SCX
column in the UHPLC system. The proposed solution is to carry out separation in
one column while the other one will go through equilibration protocol to become
available immediately after the first column has completed an entire run.
The UHPLC-SCXC experiments have been using the concentration gradient
mode of cation exchange chromatography which elutes the bound molecule in the
column by increasing the concentration of the mobile phase. In the scenario of the
immunocomplex being eluted at the same period of time to either the IgG antibody
or β-endorphin, pH gradient mode of cation exchange chromatography can be
applied. pH gradient mode increases the pH of the mobile phase over time instead
of increasing the concentration. The formation of the immunocomplex will possibly
block one or more cationic site of β-endorphin and/or IgG antibody which will
modify the isoelectric point of the complex. pH gradient cation exchange
chromatography will ensure different migration time of the complex with modified
isoelectric point.

4.4 Immunoassay of β-endorphin and Oxytocin
Following SCXC-based non-competitive immunoassay method and performing
necessary crosslinking procedures, β-endorphin and oxytocin will be measured.
Known concentration samples will be assayed to build up a calibration curve for
both assays. The calibration curves for both assays will provide the information
that how the concentration of antibody-analyte complex changes with the change
in concentration of sample analyte. The desired limit of detection for the assays is
in the range of high pM to low nM.
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4.5 Conclusion
Despite implementing the crosslinking protocol to establish additional covalent
bonds between the antigen and the antibody, SCX based immunoassay failed to
demonstrate a peak of the immunocomplex in the chromatogram. It can be implied
the crosslinking agents were not successful to establish a stable covalent bond
between the molecules. The functionality of the crosslinking agents is dependent
on the spacer arm length. Spacer arm length is the physical length of the
crosslinking agent and the appropriate distance of the functional groups in the
antigen and the antibody. The proposed crosslinking agents had spacer arm
lengths of 7.3 Å and 11.6 Å respectively. The distance between the primary amine
group in the beta-endorphin structure and the free sulfhydryl group in the antibody
has to match the spacer arm length of the applied crosslinking agent. The failure
of the protocol can be attributed to use of improper crosslinking agent. Several
other crosslinking agents reactive towards primary amines and sulfhydryl groups
with different spacer arm lengths can be used to stabilize the immunocomplex.
Sulfo-SMCC (8.3 Å), Sulfo-EMCS (9.4 Å), Sulfo-SIAB (10.6 Å), Sulfo-LC-SPDP
(15.7Å), PEG4-SPDP (25.7 Å), and PEG12-SPDP (54.1 Å) are potential aminesulfhydryl crosslinking agents with different spacer arm lengths than previously
used. X-ray diffraction techniques can be used to determine the 3D structures of
the antigen and the antibody to understand the relative distance of the amine
groups in the antigen and the sulfhydryl group. The study will help choose an
appropriate crosslinking agent to stabilize the immunocomplex. Stabilized
immunocomplex will lead to successful immunoassays of the proposed antigens.
An alternate postulation of inability of appearing the immunocomplex peak in
the chromatogram maybe attributed to the inability of resolution of the antibody
and the immunocomplex peak. The immunocomplex peak was assumed to appear
in the intermediary zone of the antibody and antigen based on the discussion in
4.1. Resolution of poorly resolved peaks in chromatograms can be improved by
implementing the principles of equation 4. Further method optimization focused on
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increasing number of theoretical plates, improving selectivity, and increasing
retention factors may be necessary. Number of theoretical plates can be increased
by using smaller stationary phase particles. Selectivity and retention factors can
be improved by reducing mobile phase flowrate, which will be a trade-off with
analysis time.
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Chapter 5
5. Future work
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5.1 Objective
The work described in chapter 2 successfully reports viability of rodent SCN
slices in the novel microfluidic perfusion device. The work has numerous future
possible directions to improve the current device and the perfusion system. The
current device is only intended to house SCN slices, but perfusion experiments
can be carried out for a variety of sources of rodent brain slices. An alternate fluid
delivery system to the continuous gas/fluid flow can be explored for simplification
and improvement of precise stimulus delivery purpose. The prospect of changing
the chamber geometry needs to be explored. Various sizes and shapes of the
chamber can be characterized for seamless laminar fluid flow. The surface energy
inside the chamber can also be characterized to improve the fluid flow. Finally, the
modifications can be optimized to achieve seamless fluid flow and least carryover
issues.

5.2 Alternate fluid delivery system
The current device uses a combination of a syringe pump and a cylinder valve
to deliver the aCSF and carbogen gas, respectively. The current delivery system
can generate alternate droplets of aCSF and bubbles of carbogen gas at the Tjunction of the device channels. A new approach of the fluid delivery system is
shown in Figure 29. In all the panels of Figure 29, carbogen gas, stimulus solution,
and aCSF media are shown to enter the device through the horizontal inlet, top
vertical inlet, and bottom vertical inlet, respectively. In this approach, carbogen gas
and aCSF media flow will be controlled using pneumatic valves where the duration
of slice interaction with the bubbles and droplets can be easily controlled and
manipulated. Instead of a continuous flow, the bubbles and droplets can remain
stagnant in the chamber for any period intended according to the experiment
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Figure 29: Proposed modified fluid delivery system

necessity. A separate pneumatic valve will be used to deliver occasional stimulus
to the slice in lieu of aCSF media. This modification to the fluid delivery system can
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enhance the nutrient supply, reduce reagent usage, and improve measurement
sensitivity of consequent perfusate analysis.

5.3 Size and shape of the device chamber
Rodent brain slices from different regions of the brain can have a variety of
sizes and shapes. Typical dimensions of some widely used rodent brain slices in
culture experiments are listed in Table 2. The geometrical features of a media
droplet changes when it enters the culture chamber from the narrower rectangular
channels. Consequently, the droplets are prone to be disintegrated due to abrupt
change of dimension. The droplets are also observed to remain stagnant inside
the culture chamber if the volume is roughly < 50% of the chamber volume.
Additionally, the shape of the chamber guides the change in length to width ration
of a droplet. The droplets are more prone to be disintegrated if the chamber shape
compels significant width expansion and length contraction. The size of the culture
chamber needs to be customized according to the size of the intended tissue slice
size. The current device uses a square shaped chamber to house the rodent brain
slices. The square shape of the chamber was selected based on a series of
qualitative trial and error attempts where the minimum disintegration and
coalescence of aCSF droplets were observed. The impact of the size and shape
of the chamber needs to quantitatively be investigated and the variables need to
be optimized for intended tissue slices. The future work will explore all the possible
shapes of the chamber (see appendix A, Figure 34) at different sizes quantitatively
for seamless laminar flow of fluids and minimum carryover issues.

5.4 Surface energy of the device chamber
The surface inside the device chamber plays an important role for seamless
laminar fluid flow and minimum carryover issues. In the current device, top of the
chamber is sealed with the hydrophilic side of a GelBond film to facilitate proper
tissue adhesion. The bottom of the chamber is the glass surface of the device. The
bottom surface can be modified to increase or decrease the hydrophilicity and
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Table 2: Dimensions of widely used rodent brain slices in culture
experiments
Regions of rodent brain slice

Typical dimensions (mm x mm)

Whole brain slice – sagittal plane [10]

12 x 8

Hippocampus slice – coronal plane

4 x 2.5

SCN slice – axial plane

1.2 x 1

study its effect on the seamless laminar flow of fluids and carryovers issues.
An additional layer of either the hydrophilic or the hydrophobic side of a GelBond
film can be used to modify the surface energy inside the device chamber. The
device can be alternatively fabricated using PMMA instead of glass to modify the
surface energy. The contact angles of a droplet of water on all three proposed
materials are shown in Figure 30. All the proposed surface materials can be
studied to ensure seamless laminar flow of fluids and minimum carryover issues.

5.5 Carry-over analysis
Carryover can be defined as the remnant of aCSF from a previous droplet that
has left the chamber. The carryover issue is particularly detrimental for perfusate
analysis since it can alter the true concentration of the secreted molecules and
decrease temporal resolution of the analysis. Carryover of aCSF droplets will be
studied with respect to the changes of each variable discussed in this chapter. The
optimized conditions for each of the variables achieving minimum carryover issues
will be determined.

5.6 Summary
Achieving the goals discussed in this chapter will provide an improved version
of the microfluidic brain slice culture device described in chapter 2. The device
will be able to house brain slices from several regions irrespective of size and
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Figure 30: Contact angles of a water droplet on various surfaces

shape. Seamless flow of media droplets will be ensured by introducing
stagnant droplet approach and optimized surface energy inside the chamber
region resulting in eliminating disintegration and coalescence.
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APPENDIX A

Figure 31: Tissue immobilization via physical structures
In panel i, a clip like structure fashioned out of a GelBond film is used to hold the
slice in the chamber. In panel ii, iii, and iv two hook like structures are fashioned
out of GelBond films to hold the tissue in the chamber. In panel iii and iv, additional
pool like physical structures fashioned out of PDMS and etch by hydrofluoric acid
are introduced respectively to provide additional immobilization to the slice. In all
four panels, disintegration and stagnation of media droplets are visible.
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Figure 32: Lag and Rise time
a An example plot of lag time and rise time for a 300 nM fluorescence injection and
b the estimation of the lag and rise time of the effect of stimuli delivered to the
device. The average lag and rise time for the fluid delivery system was 92 s and
127 s respectively.
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Figure 33: Calibration plots for
quantitative smartphone imaging experiments
Calibration plots are shown with linear fit (red), upper (green), and lower (blue)
bounds of the 95% confidence band of the linear fit for illumination conditions
including a. sunlight, b. fluorescent office illumination with smartphone flashlight,
c. fluorescent office illumination without the use of flashlight, and d. dark ambient
light with smartphone flashlight. The full width of the 95% confidence interval as a
function of measured epinephrine concentration is shown in e.
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Table 3: [Epinephrine] in the discolored EAIs measured by UHPLC

Sample
ID

Epinephrine
Concentration
(mg mL-1)

S2
S3
S5
S6
S7
S8
S9
S11
S12
S13
S14
S15
S16
S22
S24
S25
S26
S27
S28
S29
S31
S32
S33

1.28
0.88
1.43
0.82
0.52
0.88
0.32
0.82
0.93
0.94
0.92
0.74
0.88
0.69
0.05
1.40
0.89
1.04
1.01
1.26
1.16
1.28
0.39
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Figure 34: Slice culture chamber designs of various shapes and sizes
i. square small, ii. square medium, iii. square large, iv. diamond small, v. diamond
medium, vi, diamond large, vii. oval small, viii. oval medium, and ix. oval large
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APPENDIX B
SOP for synthesis of Chitosan-Dextran based glue

Part A: Preparation of Chit-HCl (chitosan hydrochloride)
1. Weigh 10 g of high molecular weight chitosan and transfer to a 250 mL
beaker
2. Slowly mix 60 mL of HCl into 40 mL of ethanol in a fume hood
3. Carefully pour the HCl-ethanol mixture into the 250 mL beaker containing
chitosan
4. Put a stir bar in the beaker and gently stir (100 rpm) the mixture for 3 hours
at room temperature.
5. After 3 hours filter off the Chit-HCl salt using a gravity filter
6. Make a 6:2 acetone-water mixture
7. Wash the Chit-HCl salt extensively with acetone-water mixture while still on
the filter paper
8. Put the Chit-HCl salt inside a dialysis tubing (MWCO 12 KDa)
9. Tie both ends of the dialysis tubing firmly to prevent any leaks
10. Put the dialysis tubing in a 1000 mL beaker in such a manner so that the
bottom of the tubing does not touch the floor of the beaker. You may use
binder clips to hold both ends of the tubing on the wall of the beaker,
essentially making a U-shape for the tubing
11. Fill the 1000 mL beaker with ultra-pure water (>14.1 MΩ) and put a stir bar
in the beaker
12. Gently stir (100 rpm) the water in the 1000 mL beaker for 2 hours
13. Change the water in the beaker and repeat steps 11-13 for 3 times
14. Pour 2 mL water from the 1000 mL beaker into a test tube and add a few
drops of 1 wt% AgNO3(aq) solution. If white precipitate appears due to
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presence of HCl in the water, repeat steps 11-14 until no precipitate
appears.
15. Transfer the solution from inside of the dialysis tubing to a glass vial.
16. Freeze dry the solution
17. Store the freeze-dried Chitosan-HCl at 4˚C until use

Part B: Preparation of DDA (dextran dialdehyde)
1. Weigh 5 g of dextran and transfer to a 250 mL beaker
2. Weigh 4.5 g of sodium metaperiodate and transfer to the same beaker
3. Add 100 mL of ultra-pure water (>14.1 MΩ) to the beaker
4. Add a stir bar in the beaker
5. Cover the beaker with aluminum foil to prevent exposure of light
6. Stir gently (100 rpm) the mixture in the beaker for 6 hours
7. Take 5 mL of the solution and transfer it inside a dialysis tube (MWCO 12
KDa)
8. Tie both ends of the dialysis tubing firmly to prevent any leaks
9. Put the dialysis tubing in a 1000 mL beaker in such a manner so that the
bottom of the tubing does not touch the floor of the beaker. You may use
binder clips to hold both ends of the tubing on the wall of the beaker,
essentially making a U-shape for the tubing
10. Fill the 1000 mL beaker with ultra-pure water (>14.1 MΩ) and put a stir bar
in the beaker
11. Gently stir (100 rpm) the water in the 1000 mL beaker for 2 hours
12. Change the water in the beaker and repeat steps 10-12 for 3 times
13. Pour 2 mL water from the 1000 mL beaker into a test tube and add a few
drops of 1 wt% AgNO3(aq) solution. If white precipitate appears due to
presence of I- in the water, repeat steps 10-13 until no precipitate appears.
14. Transfer the solution from inside of the dialysis tubing to a glass vial.
15. Freeze dry the solution
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16. Store the freeze-dried DDA at 4˚C until use

Part C: Formation of the two-part hydrogel glue
1. Obtain phosphate buffer saline (PBS)
2. Hydrate Chit-HCl with PBS to form a 5 wt% solution
3. Hydrate DDA with PBS to form a 10 wt% solution
4. Apply 2 µL of each solution on the hydrophilic side of a GelBond film to
adhere a typical rodent SCN slice. The volume of each part may vary for
different dimension of tissue slices.

118

VITA
Amirus Saleheen was born and brought up in Narayanganj, Bangladesh. He
graduated from Narayanganj Ideal High School, Narayanganj in 2005 and Dhaka
City College, Dhaka in 2007. He earned his bachelors of science degree with a
major in applied chemistry and chemical engineering from the University of Dhaka,
Bangladesh in August 2012. While in the University of Dhaka, he grew a keen
interest in higher study in analytical chemistry. After graduating from the University
of Dhaka, he started teaching chemistry to high school students alongside
preparing to apply for graduate admission in the United States. He joined the
graduate program in the department of chemistry at the University of Tennessee
at Knoxville in August 2015 and shortly after was accepted into the research group
of Dr. Christopher A. Baker. In the Baker lab, he has been involved in several
projects focused on analytical challenges in biological applications involving
microfluidics and chemical separation. His work has resulted in numerous peerreviewed publications and presented several times in national conferences.
Amirus will receive his Ph.D. in Analytical Chemistry in Summer 2020.

119

